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ABSTRACT
We develop novel semiparametric methods for flexibly modeling a prevalence indicator process
observed over follow-up time. The proposed methods are motivated by various settings arising in
end-stage renal disease (ESRD) and end-stage liver disease (ESLD).
In Chapter 1, we consider the response Survival-Out-of-Hospital, defined as a temporal process
taking the value 1 when the subject is currently alive and not hospitalized, and 0 otherwise. The
semiparametric model we consider assumes multiplicative covariate effects and leaves unspecified
the baseline probability of being alive-and-out-of-hospital. Asymptotic properties are derived, and
simulation studies are performed. The proposed methods are applied to the Dialysis Outcomes and
Practice Patterns Study (DOPPS), a prospective international ESRD study.
In Chapter 2, we extend the methods from Chapter 1 to accommodate dependent censoring. We
derive a modification of Inverse Probability of Censoring Weighting which offers improved stabil-
ity and reduced computational burden relative to the traditional IPCW. We show that the regression
estimator is asymptotically normal, and that the baseline probability function estimator converges
to a Gaussian process. The methods are used to model the probability of being alive and active on
the liver transplant waiting list, which can be dependently censored by liver transplantation.
In Chapter 3, we jointly model prevalence conditional on survival, and the death hazard. A
frailty is shared by the prevalence and hazard models, with the frailty effect scaled in the latter. We
propose an iterative procedure for estimating the regression parameters by updating frailties from
their implied estimating equations. The scale parameter and random effect variance are estimated
by numerical integration. The algorithm is asymptotically equivalent to an EM algorithm which
treats the frailty terms as missing data. We apply the methods to DOPPS data.
viii
CHAPTER 1
Semiparametric Temporal Process Regression of
Survival-Out-of-Hospital
1.1 Introduction
Often in clinical or epidemiological studies, both a recurrent event process and terminal event
are of interest. This is particularly true given the recent proliferation of administrative databases
available for secondary analysis. Correspondingly, a considerable number of methods have been
developed for the recurrent/terminal event data structure. One option is to model the marginal
mean/rate [Cook and Lawless, 1997, Ghosh and Lin, 2002, Schaubel et al., 2006, Cook et al.,
2009], essentially averaging over the survival experience. Another class of approaches involves
jointly modeling survival and the conditional recurrent event rate given survival [Huang and Wang,
2004, Liu et al., 2004, Ye et al., 2007, Zeng and Cai, 2010, Kalbfleisch et al., 2013].
In this report, we study a useful alternative framework for the analysis of recurrent/terminal
event data. In particular, a frequently arising example of this data structure involves hospitaliza-
tion representing the recurrent event, with death serving as the terminal event. Although hospital
admission can be regarded as a point process, the length of stay for a hospitalization may be several
days and, therefore, should not be ignored in the analysis. This concept is recognized in the works
of Hu et al. [2011] and Zhu et al. [2014], for example. Survival-out-of-hospital may be viewed as a
refinement of survival time in the study of chronic illness such as end-stage renal disease (ESRD),
with the refinement being the incorporation of each patient’s hospital admission and length of stay
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information. An appealing characteristic of survival-out-of-hospital is that it incorporates mor-
bidity data in an objective and easily understood manner. Data of this structure are increasingly
available, given the relatively recent proliferation of publicly available health administrative data
sets [Holland and Lam, 2000, Sands et al., 2006, Carson et al., 2009].
Temporal process regression would appear to be a natural conceptualization of survival-out-of-
hospital. Several process regression methods have been proposed in the last decade. For example,
Fine et al. [2004] developed functional generalized linear models, for which covariates effects are
completely unspecified and are estimated nonparametrically over time. Such an approach has also
been generalized to multivariate survival settings to model both mean and association structures
[Yan and Fine, 2005]. To increase precision, the partly functional temporal process model has
been developed, with covariate effects being nonparametric for some covariate elements and para-
metric for others [Yan and Huang, 2009, Estes et al., 2015]. These functional generalized linear
models generally focus on time-varying covaiate effects. In addition, martingale-based estimating
equations have been proposed for directly modeling survival function by solving a sequence of
monotone equations [Peng and Huang, 2007]. Approaches listed in this paragraph are part of the
inspiration for the methods we propose in this report. However, as will become more clear later
in our report, none of these approaches are applicable to our setting given the specifics of analytic
objectives, along with the assumed data structure and model of interest.
Various other existing methods are pertinent to the data structure of our interest, but not ap-
plicable to our research question. For instance, methods proposed in Andersen et al. [2003] and
Scheike and Zhang [2007] involved direct modeling of a state transition probability or a state occu-
pation probability in a multi-state model. In these approaches, each state is assumed to be visited
not more than once. As such, none of these approaches are directly applicable to our particular
research question and data structure, since patients can move in and out of hospital many times
prior to death. In addition, pseudo-observation approaches [Andersen et al., 2003, Grand and Put-
ter, 2016], despite their utility, generally only allow for censoring that does not dependent on the
covariate vector, an assumption that may be violated in observational studies. As described in
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Section 2, the methods we propose allow censoring to depend on the covariate vector.
In this report, we propose a semiparametric temporal process regression method, where co-
variates have multiplicative effects on a completely unspecified baseline probability function. This
model can be thought of a process version of the generalized linear model with the process indexed
by time. In terms of estimation, the regression parameter is estimated by the solution to an esti-
mating equation which is free of the baseline probability function. We propose a nonparametric
estimator for the baseline probability process, a closed form for which can be computed after esti-
mating the regression parameter. The estimating functions do not require inverse weighting in the
setting where censoring times are known (e.g., if all censoring was administrative, occurring at the
same calendar date). To accommodate the more commonly occurring scenario where censoring
is random, we employ multiple imputation [Little and Rubin, 2002] to recover censoring times
unobserved due to death [Schaubel and Zhang, 2010].
Our method has several distinguishing features. First, covariate effects are on the relative risk
scale, as opposed to odds ratio. The baseline probability process is specified as a nonparametric
function of follow-up time, to increase flexibility and robustness. Through a development that
parallels the derivation of the Cox partial likelihood score function [Cox, 1972a], we derive an
estimating function for the regression parameter that is free of the baseline probability function.
This reduces the complexity of computation and permits the use of standard statistical software.
Moreover, the baseline probability function can be subsequently estimated at any specific time
point before the maximum observation time. We also propose estimating the integral of the base-
line probability, which can then be used to predict expected survival time out-of-hospital over a
finite time interval.
In this article, we are interested in the joint event of being out-of-hospital and being alive.
This response variable takes quality of life information into consideration, while leaves the depen-
dent structure between temporal indicator and terminal event completely unspecified. More model
details and challenges are illustrated in the following section. Our method is different from the
current practice in clinical trials which use the time to the first recurrent event or terminal event
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[Lewis, 1999, Pfeffer et al., 2003], and is also distinct from a weighted composite endpoint of all
recurrent and terminal events [Neaton et al., 2005, Mao and Lin, 2016].
The remainder of the article is organized as follows. In Section 2, we introduce notations, for-
mulate model assumptions, and propose estimating procedures for parameters and baseline prob-
ability function. In Section 3, we show that the regression parameter estimator converges to a
Normal distribution, and estimator of the baseline probability function converges to a Gaussian
process. Simulation studies are performed to evaluate our method under various scenarios in Sec-
tion 4. We also illustrate our method through an analysis of survival-out-of-hospital using data
from the Dialysis Outcomes and Practice Patterns Study (DOPPS), a long-running international
prospective study of ESRD patients. Finally, concluding remarks are provided at Section 6.
1.2 Model and Methods
Suppose there are a total of n independent subjects. Let Di denote the death (terminal event) time
of subject i (i = 1, 2, ..., n). We let Ci be the censoring time, and let Zi(t) be a p-dimensional
covariate vector which may contain time-varying elements (assumed to be external; Kalbfleisch
and Prentice [2002], p.g. 196). Here, we consider follow-up time t ∈ [0, τ ], where τ is a pre-
specified constant satisfying Pr(Ci ≥ τ) > 0 for i = 1, 2, ..., n. In practice, τ could be chosen as
the maximum of observation time, Ci ∧Di, where a ∧ b = min(a, b).
Let Hi(t) = 1 if subject i is in the hospital at time t, and 0 if out of hospital. The probability
of interest is the probability that a subject i is alive and out-of-hospital at time t, i.e.,
πi(t) = P{Hi(t) = 0, Di > t|Zi(t)}. (1.1)
We assume that the covariates have multiplicative effects on an unspecified baseline probability
function π0(t), such that
πi(t) = π0(t)exp{βT0Zi(t)}, (1.2)
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where β0 is a p-dimensional vector. This is similar to the Cox proportional hazard assumption
[Cox, 1972a], but πi(t) is interpreted as the probability of being out of hospital and alive for
subject i at time t. Note the distinction between (1.2) and an intensity [Andersen and Gill, 1982]
or marginal rate function [Lin et al., 2000].
For brevity of notation, we define Ai(t) = I{Di > t} as the alive indicator, and A0i (t) =
I{Hi(t) = 0, Di > t} as the survival-out-of-hospital indicator. Similar we could define A1i (t) =
I{Hi(t) = 1, Di > t} as survival-hospitalized indicator. In this report we are interested in A0i (t),
while people could also focus on A1i (t). It is important to note that information is still available on
subject i before the censoring time, even after the terminal event has occurred. Note thatA0i (t) = 0
for t ∈ [Di, Ci] if Di < Ci.
1.2.1 Known Censoring
To begin, suppose that censoring time Ci is always known. This would be the case in a closely
monitored prospective study from which patients could not be randomly lost to follow-up. In such
cases, Ci is known even if Ci > Di. This set-up does not match most observational studies, but it
is a useful starting point. We assume that censoring time is independent of our target event A0i (t),
conditional on Zi(t); more explicitly, we can express the assumption as follows,
E{A0i (t)|Zi(t), Ci ≥ t} = E{A0i (t)|Zi(t)}. (1.3)







i (t)− πi(t)]I(Ci ≥ t)dt (1.4)
n∑
i=1
[A0i (t)− πi(t)]I(Ci ≥ t). (1.5)
These estimating functions have expectation zero under model (1.2) and assuming conditionally
independent censoring (1.3). Note that equation (1.5) could be evaluated at any specific time point
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t ∈ [0, τ ], and does not have to be an observed event time. Solving equation (1.5) for π0(t) treating
β0 as known, then substituting the resulting π̂0(t) back into equation (1.4) yields the following






{Zi(t)− Z̄(t;β)}A0i (t)I(Ci ≥ t)dt = 0, (1.6)




for k = 0, 1, 2, where a⊗0 = 1, a⊗1 = a, and a⊗2 = aaT . We also define the following notations.
Let s(k)(t;β) = E[Z1(t)⊗kI(C1 ≥ t)exp{βTZ1(t)}] and z̄(t;β) = s(1)(t;β)/s(0)(t;β) be the










{s(2)(t;β)/s(0)(t;β) − z̄(t;β)⊗2}A01(t)I(C1 ≥ t)dt]. Observed data for subject i
can be summarized by Fi = {Hi(t), Di ∧ Ci, I(Di ≥ Ci),Zi(t), t ∈ [0, Xi]} for i = 1, 2, ..., n,
where Xi = Di ∧ Ci.
Equation (1.6) is reminiscent of the Cox regression score function, a property which can be
exploited computationally (i.e., to ease programming effort). For instance, if the time scale is
days (like our real-data application in Section 5) or some other discrete measure, then standard
proportional hazards software (e.g., coxph(·) in R, proc phreg in SAS) can be used after augmenting
the data set. Specifically, the augmented data would contain one record for each time unit t a
subject is uncensored, with the event indicator for time unit t would be A0i (t). Such data would left
truncated such that, within subject, the (j + 1)th record begins (i.e., its left subinterval boundary)
where the jth records ended (i.e., its right interval boundary). Alternatively, if the time scale
were truly continuous, then the augmented data would contain, for each subject, one record for
every time at which Zi(t), Z̄(t;β), or A0i (t) changes. Additionally, for the jth record of subject
i spanning, say, (tj−1, tj], a weight of (tj − tj−1) would be used, along with offset log(tj − tj−1).
Note that the Breslow approximation (for tie-handling) would be used, as is the default in SAS’s
phreg. Naturally, an alternative is to write explicit code to solve (1.6) using Newton-Raphson.
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i (t)I(Ci ≥ t)∑n




Note that π̂0(t) is closely related to the Breslow estimator of baseline cumulative hazard function
[Breslow, 1972]. However, π0(t) is bounded above by 1, since it corresponds to a probability.
With respect to leveraging standard software, π̂0(t) can be computed directly through successive
differencing in the previously described scenarios wherein the time scale is discrete (with one
record per uncensored time unit per subject). If time is continuous, then π̂0(t) would need to be
computed explicitly, with the value changing each time, for any subject i in the data set, either of
A0i (t), or I(Ci ≥ t) or Zi(t) changes its value.
Note that, due to the use of the log link, π̂0(t) > 1 is possible. This could occur, for example,
in settings wherein hospitalization and mortality rates are low. One solution is to cap π̂0(t) by 1.





which could be interpreted as the expected length of being alive and out-of-hospital up to time L




π̂0(t) in (1.7) would jump up when subjects are discharged from the hospital, and jump down if
subjects are admitted to the hospital or dead. This property would facilitate computation in real
data application, because Π̂0(L) would be a sum of rectangular area with height π̂0(t) and length
in recorded unit, for example day.
1.2.2 Random Censoring
Now, consider the more typical scenario in which the censoring time Ci is not fixed at t = 0, with
its randomness implying that Ci is not known in cases where Di is observed for subject i. In this
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set-up, one cannot carry out estimation through (1.6) and (1.7), defined in the preceding subsection,
due to Ci being missing for subjects observed to die. A simple solution is to set censoring time as
the maximum follow-up time across all subjects, which may lead to substantial bias in estimating
β0 and π0(t). Similarly, setting censoring time as Di for subjects with Ci > Di would generally
lead to invalid inference.
One could use weighting techniques to recover missing censoring time, essentially weights
subjects with Ci > Di by a conditional survival probability [Ghosh and Lin, 2002, Mao and Lin,
2016]. However, a weighted version of estimating equation (1.6) is tedious to carry out, since the
time line is continuous. In this report we consider an alternative imputation approach which is easy
to implement by standard software.
Our solution is to multiply impute Ci when Di < Ci and, for this purpose, we assume the
following proportional hazard model on the censoring time,
λCi (t) = λ
C
0 (t)exp{θT0Zi(t)}, (1.9)
where λC0 (t) is an unspecified baseline hazard function for Ci. In light of the model for Ci, we
now define the corresponding counting process NCi (t) = I(Ci ≤ t ∧ Di), and its increment
dNCi (t) = N
C
i (t
− + dt) − NCi (t−). Similarly, the counting process for death time is defined
by NDi (t) = I(Di ≤ t ∧ Ci). Let Yi(t) = I(Xi ≥ t) be the at risk process. Standard partial
likelihood [Cox, 1975] techniques can be fitted to the observed censoring time data {Xi, I(Ci ≤
Di),Zi(t); t ∈ [0, τ ]}ni=1 to compute θ̂, which can be shown to be a strongly consistent estimator
of θ0 [Andersen and Gill, 1982]. The baseline cumulative hazard function for ΛC0 (t) is estimated
through the method of Breslow [Breslow, 1972].
We will create M imputed datasets, where normally M = 10 would suffice. The proposed
methods are also valid for M = 1, although this would be less efficient. Consider the mth imputed
dataset, for subjects with Ci ≤ Di, we set imputed censoring time as the known censoring time.




the estimated conditional survival function,
Ĝ(t; θ̂) = I(t ≥ Di)exp[−Λ̂Ci (t; θ̂) + Λ̂Ci (Di; θ̂)] (1.10)
More explicitly, we could express the imputed censoring time C〈m〉i as
C
〈m〉
i = [1−NDi (Xi)]Ci +NDi (Xi)Ĉ
〈m〉
i .
We make the following notations. First consider the uncensored indicator I(C〈m〉i ≥ t;θ),
where we include θ in the parenthesis to emphasize that C〈m〉i depends on imputation parameter
θ. In finite samples, we impute Ĉ〈m〉i from Ĝ(t; θ̂) for subjects with Ci > Di to obtain I(C
〈m〉
i ≥
t; θ̂). Define G(t;θ0) = I(t ≥ Di)exp[−ΛCi (t;θ0) + ΛCi (Di;θ0)]. Therefore, I(C
〈m〉
i ≥ t;θ0)
refers to a hypothetical scenario where we impute Ĉ〈m〉i from the true underlying G(t;θ0) when
Ci > Di. When (1.9) is correctly specified, I(Ci ≥ t) and I(C〈m〉i ≥ t;θ0) follow exact the
same distribution. The notation I(C〈m〉i ≥ t;θ0) is useful for the establishment of asymptotic
properties. Also note that A0i (t)I(C
〈m〉
i ≥ t; θ̂) = A0i (t)I(C
〈m〉
i ≥ t;θ0) because A0i (t) = 0










1 ≥ t;θ)exp{βTZ1(t)}] be the limiting value ofS(k)〈m〉(t;β,θ)
for k = 0, 1, 2. Also let Z̄〈m〉(t;β,θ) = S(1)〈m〉(t;β,θ)/S(0)〈m〉(t;β,θ), and denote its limiting








{S(2)〈m〉(t;β,θ)/S(0)〈m〉(t;β,θ) − Z̄〈m〉(t;β,θ)⊗2}A0i (t)I(C
〈m〉
i ≥







For the mth imputed data set, the estimation of β0 and π0(t) is as defined in Section 1.2.1, but
with Ci replaced by C
〈m〉
i . More explicitly, β̂
〈m〉
is computed by solving the following estimating
equation,






















i ≥ t; θ̂)∑n
i=1{I(C
〈m〉



































The estimator π̂M0 (t) given in (1.14) is easier for us to develop the asymptotic properties, because
both the numerator and denominator can be expressed as empirical processes indexed by time t.




We assume the following set of regularity conditions:
(a) {Hi(t), Xi, I(Ci ≤ Di),Zi(t)} for t ∈ [0, Xi], i = 1, 2, ..., n are independent and identically
distributed.




|dZij(t)| < cZ <∞ almost surely for i = 1, 2, ..., n, j = 1, 2, ..., p, i.e.,Zi(t)
has bounded total variations.
(d) Ω(β0) = E[
∫ τ
0
{s(2)(t;β0)/s(0)(t;β0)− z̄(t;β0)⊗2}A01(t)I(C1 ≥ t)dt] is positive definite.
(e) For β ∈ Bδ, where Bδ is a small neighborhood around β0, s(0)(t;β), and s(1)(t;β) are
bounded away from zero.
(f) For β ∈ Bδ, k = 0, 1, 2, s(k)(t;β) are continuous uniformly on t ∈ [0, τ ], and are bounded
on [0, τ ]×Bδ.
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We summarize the essential asymptotic properties of β̂, π̂0(t) and imputed versions β̂
M
, π̂M0 (t) in
the following theorems. Proofs are sketched in the Supplemental Materials.
1.3.1 Known Censoring
We begin by describing the asymptotic properties of estimators applicable to the known-censoring
set-up from Section 1.2.1.
Theorem 1. Under assumptions (1.2) and (1.3) and the afore-listed regularity conditions, β̂ is
a consistent estimator of β0, and n
1/2(β̂ − β0) converges in distribution to a mean-zero Normal








{Zi(t)−z̄(t;β)}dMi(t;β), and dMi(t;β) = A0i (t)I(Ci ≥ t)dt−exp[βTZi(t)]I(Ci ≥














We now describe the asymptotic behavior of π̂0(t) from (1.7).
Theorem 2. Under assumptions (1.2) and (1.3), n1/2(π̂0 − π0) converges weakly to a mean-
zero Gaussian process with a variance and covariance matrix between n1/2[π̂0(s) − π0(s)] and






and fπ1i (t;β) = A
0
i (t)I(Ci ≥ t)−exp[βTZi(t)]I(Ci ≥ t)π0(t), f
π2




fβi (β) = Ω(β)
−1ui(β). A consistent estimator of σ(s, t) is given by its empirical counterparts














Now we describe the limiting behavior of estimator for the random-censoring set-up from Section
1.2.2.
Theorem 3. If censoring mechanism (1.9), assumptions (1.2) and (1.3) are correctly specified,
then under the previously listed regularity conditions, β̂
M
is a consistent estimator of β0, and
n1/2(β̂
M










where u〈m〉i (β,θ) =
∫ τ
0
{Zi(t)− z̄〈1〉(t;β,θ)}dM 〈m〉i (t;β,θ),








A consistent estimator of ΣM(β0,θ0) is given by
Σ̂M(β̂
M






















The asymptotic behavior of imputed version π̂M0 (t) from (1.14) is summarized in the following
theorem.
Theorem 4. If censoring mechanism (1.9), assumptions (1.2) and (1.3) are correctly specified, then
n1/2(π̂M0 −π0) converges weakly to a mean-zero Gaussian process with a variance and covariance




















































We evaluate the finite-sample performance of our method through simulation studies. For each
setting, n = 500 subjects are generated. Elements of the covariate vector, Z = (Z1, Z2)T , follow
either a Bernoulli(0.5) or a Uniform(0, 1) distribution. The target model is survival-out-of-hospital
probability, π(t) = π0(t)exp{βT0Z}, where π0(t) = 0.3−0.0025t, for t = 1, 2, ..., 100. This model
of the joint outcome can be generated through the hazard function for death time D, λD(t), and
P{H(t) = 0|D > t,Z}. We set λD(t) = λD = λD0 exp(αT0Z), where λD0 = 0.012 or 0.006
and α0 = (0.405,−0.405)T . In this case, the out-of hospital event given the subject is alive is
sampled from the conditional probability P{H(t) = 0|D > t,Z} = π(t)exp(λDt). Censoring





γ0 = (−0.693, 0.693)T , such that C and the target event I{H(t) = 0, D > t} are independent
given covariates Z.
In Table (1.1), we consider the scenario where censoring times are known for all subjects. For
Table (1.2) and (1.3), censoring time C is unknown in cases where death time D is observed, i.e.
C > D, and imputation method with M = 1 and 10 are evaluated. The baseline terminal event
hazard function λD0 are considered at 0.012 and 0.006, which result in about 49% and 68% subjects
are censored, respectively. Three different magnitudes of β0 are considered: 0.693, 0.405 and 0.
In each setting, the biases of β̂ and Π̂0(50) are very small, indicating that our estimators are
consistent. Moreover, empirical standard deviations (ESDs) are generally close to the average
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Table 1.1: Simulations Results for Known Censoring Time based on n = 500 and 500 Replicates
β̂
λD0 Z True BIAS ASE ESD ECP
0.012
Binary
(0.693, -0.693) (-0.005, 0.000) (0.069, 0.069) (0.069, 0.067) (0.964, 0.956)
(0.405, -0.405) (0.001, 0.002) (0.066, 0.066) (0.065, 0.067) (0.954, 0.956)
(0.000, 0.000) (-0.001, 0.000) (0.062, 0.062) (0.064, 0.062) (0.944, 0.956)
Uniform
(0.693, -0.693) (-0.002, -0.010) (0.114, 0.114) (0.120, 0.115) (0.942, 0.942)
(0.405, -0.405) (-0.014, 0.005) (0.110, 0.110) (0.104, 0.107) (0.966, 0.944)
(0.000, 0.000) (0.003, 0.009) (0.105, 0.105) (0.100, 0.108) (0.950, 0.944)
0.006
Binary
(0.693, -0.693) (0.001, 0.000) (0.048, 0.048) (0.049, 0.050) (0.944, 0.930)
(0.405, -0.405) (-0.001, 0.002) (0.046, 0.046) (0.046, 0.048) (0.952, 0.932)
(0.000, 0.000) (0.001, 0.002) (0.044, 0.044) (0.045, 0.042) (0.946, 0.968)
Uniform
(0.693, -0.693) (-0.005, 0.001) (0.080, 0.080) (0.084, 0.084) (0.936, 0.938)
(0.405, -0.405) (-0.003, -0.003) (0.077, 0.077) (0.081, 0.080) (0.946, 0.948)
(0.000, 0.000) (0.000, 0.001) (0.075, 0.075) (0.076, 0.078) (0.956, 0.932)
Π̂0(50)




0.041 0.594 0.561 0.962
0.015 0.586 0.597 0.946
0.010 0.584 0.587 0.932
Uniform
0.075 0.957 1.021 0.942
0.054 0.940 0.875 0.958
-0.054 0.916 0.879 0.952
0.006
Binary
-0.023 0.435 0.436 0.958
0.002 0.426 0.428 0.952
-0.008 0.426 0.401 0.952
Uniform
0.026 0.683 0.732 0.926
0.045 0.670 0.697 0.950
0.007 0.661 0.674 0.924
asymptotic standard errors (ASEs), showing that our proposed variance estimator appear to be
applicable to finite samples. The empirical coverage probabilities (ECPs) are also around 0.95,
implying the accuracy of large-sample confidence intervals.
1.5 Real Data Analysis
We applied the proposed methods to data from the Dialysis Outcomes and Practice Patterns Study
(DOPPS) Phase 5. The DOPPS is a prospective, observational study designed to elucidate as-
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Table 1.2: Simulations Results for Unknown Proportional Censoring with M = 1 Time based on n =
500 and 500 Replicates
β̂
1
λD0 Z True BIAS ASE ESD ECP
0.012
Binary
(0.693, -0.693) (-0.005, 0.000) (0.069, 0.069) (0.070, 0.074) (0.938, 0.932)
(0.405, -0.405) (-0.001, 0.001) (0.066, 0.066) (0.070, 0.065) (0.944, 0.954)
(0.000, 0.000) (0.000, 0.003) (0.062, 0.062) (0.061, 0.061) (0.956, 0.956)
Uniform
(0.693, -0.693) (0.001, -0.008) (0.114, 0.114) (0.114, 0.116) (0.958, 0.942)
(0.405, -0.405) (-0.001, 0.002) (0.110, 0.110) (0.114, 0.100) (0.946, 0.960)
(0.000, 0.000) (0.003, 0.001) (0.106, 0.105) (0.104, 0.111) (0.956, 0.928)
0.006
Binary
(0.693, -0.693) (0.001, 0.002) (0.048, 0.048) (0.047, 0.049) (0.950, 0.942)
(0.405, -0.405) (-0.003, 0.002) (0.046, 0.046) (0.046, 0.045) (0.942, 0.960)
(0.000, 0.000) (0.002, -0.002) (0.044, 0.044) (0.045, 0.046) (0.950, 0.940)
Uniform
(0.693, -0.693) (0.001, 0.003) (0.080, 0.080) (0.078, 0.081) (0.948, 0.948)
(0.405, -0.405) (-0.006, -0.006) (0.078, 0.078) (0.075, 0.076) (0.958, 0.948)
(0.000, 0.000) (-0.001, -0.007) (0.075, 0.075) (0.074, 0.076) (0.952, 0.946)
Π̂10(50)




0.036 0.593 0.616 0.926
0.010 0.585 0.597 0.936
-0.005 0.585 0.585 0.946
Uniform
0.041 0.958 1.001 0.934
0.028 0.938 0.936 0.948
-0.008 0.917 0.982 0.936
0.006
Binary
-0.021 0.432 0.418 0.950
0.000 0.428 0.429 0.956
-0.009 0.425 0.444 0.936
Uniform
-0.007 0.679 0.671 0.960
0.078 0.678 0.654 0.956
0.060 0.662 0.658 0.950
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Table 1.3: Simulations Results for Unknown Proportional Censoring with M = 10 Time based on
n = 500 and 500 Replicates
β̂
10
λD0 Z True BIAS ASE ESD ECP
0.012
Binary
(0.693, -0.693) (0.003, 0.000) (0.068, 0.068) (0.067, 0.068) (0.952, 0.954)
(0.405, -0.405) (0.004, -0.001) (0.065, 0.064) (0.062, 0.064) (0.952, 0.952)
(0.000, 0.000) (0.004, -0.001) (0.060, 0.060) (0.059, 0.062) (0.948, 0.954)
Uniform
(0.693, -0.693) (-0.002, 0.008) (0.111, 0.111) (0.114, 0.107) (0.936, 0.954)
(0.405, -0.405) (-0.001, 0.007) (0.107, 0.107) (0.112, 0.103) (0.934, 0.960)
(0.000, 0.000) (-0.003, 0.007) (0.103, 0.102) (0.107, 0.098) (0.936, 0.968)
0.006
Binary
(0.693, -0.693) (-0.002, 0.003) (0.047, 0.047) (0.047, 0.046) (0.948, 0.950)
(0.405, -0.405) (0.000, 0.001) (0.045, 0.045) (0.046, 0.043) (0.954, 0.952)
(0.000, 0.000) (0.000, 0.001) (0.043, 0.043) (0.043, 0.042) (0.952, 0.960)
Uniform
(0.693, -0.693) (-0.001, 0.000) (0.078, 0.078) (0.079, 0.080) (0.950, 0.934)
(0.405, -0.405) (-0.001, 0.000) (0.075, 0.075) (0.076, 0.077) (0.954, 0.936)
(0.000, 0.000) (-0.001, 0.001) (0.073, 0.073) (0.073, 0.076) (0.958, 0.944)
Π̂100 (50)




-0.019 0.575 0.583 0.932
-0.017 0.569 0.574 0.940
-0.015 0.566 0.571 0.946
Uniform
-0.042 0.923 0.900 0.952
-0.039 0.906 0.880 0.952
-0.031 0.889 0.870 0.944
0.006
Binary
-0.013 0.421 0.411 0.954
-0.002 0.417 0.408 0.954
-0.001 0.415 0.407 0.954
Uniform
0.015 0.662 0.669 0.952
0.015 0.654 0.660 0.952
0.013 0.645 0.661 0.946
16
pects of hemodialysis practice that are associated with the best outcomes for hemodialysis patients
[Young et al., 2000]. In particular, Phase 5 data were collected between 2012 and 2015. Our
research interests include identifying demographic and clinical variables that are associated with
survival-out-of-hospital probability, and characterizing the underlying survival-out-of-hospital pro-
cess.
The study population for DOPPS is of prevalent patients. In the interests of having t reflect
time-since-dialysis-initiation instead of time-since-DOPPS-entry, we restricted our study sample
to include the n = 5, 298 patients who entered DOPPS within 3 months of initiating dialysis.
Patients included in our analysis were from 470 hemodialysis units across 11 different countries,
with the counties including: Belgium, Canada, China, Gulf Coast Consortium, Germany, Italy,
Japan, Spain, Sweden, the United Kingdom and the U.S.. Covariates include age, race, gender,
height, time on dialysis at study entry, as well as the following list of comorbid conditions: coro-
nary artery disease (CAD), cancer, cardiovascular disease (CVD), stroke, congestive heart failure
(CHF), diabetes, hypertension, chronic obstructive pulmonary disease (COPD), psychiatric disor-
der and peripheral vascular disease (PVD).
Since hospitalization and death times are recorded in days, t represents day (i.e, day post
DOPPS entry) in our analysis. The mean number of hospital admissions was 0.595 per patient,
while the median length of stay per visit was 5 days. Observed follow-up time had a median
of 326 days. Censoring time cannot realistically be considered to be fixed, since patients are fre-
quently lost to follow-up for reasons other than death or closure of the DOPPS database. To recover
missing censoring time, we created M = 10 imputed data sets as described in Section 1.2.2.
At some early time points (i.e., t < 30 days), π̂0(t) > 1 due to hospitalization and mortality
rates being low. We therefore set such probabilities to 1. As shown in Table (1.4), coronary
artery disease (p = 0.042) and cancer (p = 0.043) have significant negative effects on survival-
out-of-hospital. Patients from Italy have significantly lower survival-out-of-hospital probability
(p = 0.046) than patients from the U.S. (reference). For continuous variables, age had a significant
negative effect (p = 0.006), while height had significant positive effect (p = 0.031). The estimated
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Figure 1.1: Fitted Baseline Survival-Out-of-Hospital Probability
baseline survival-out-of-hospital probability π̂100 (t) is shown in Figure (1.1). The curve generally
decreases as follow-up time increases, although the decrease is not monotone.
1.6 Concluding Remarks
In this report, we propose semiparametric methods for analyzing the probability of survival-out-
of-hospital, a novel end-point pertinent to a frequently arising instance of the recurrent/terminal
event data structure. Estimation proceeds through estimating equations which are analogous to
those employed in Cox regression. Multiple imputation is implemented to accommodate missing
censoring times that are unobserved due to the subject dying. Asymptotic properties of estimators
are derived, and simulations studies show the proposed methods have satisfactory finite sample
performance.
We applied the methods to data from Phase 5 of the Dialysis Outcomes and Practice Patterns
Study in order to identify significant predictors of survival-out-of-hospital. Coronary artery dis-
ease, cancer and psychiatric disorder are found to be comorbidity factors with significant negative
effects on survival-out-of-hospital events for a typical DOPPS patient in the U.S.. Patients at Italy
have significantly lower survival-out-of-hospital probability than patients in the U.S.. Moreover,
increasing age had a significantly negative effect, while height had significantly positive effect.
A key advantage of the proposed methods is that the baseline probability process does not
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need to be specified. This is important, since this temporal process will often represent a nuisance
parameter. Modeling the baseline parametrically could be tedious to carry out accurately, and
could lead to bias in the regression parameter (of chief interest) if an incorrect parametric form is
assumed. Note that, although the proposed baseline estimator shares a structure similar to that of
the Breslow (1972) estimator, there are some important differences. First, our baseline estimator
is not monotone, consistent with the temporal process it is targeting. Second, the estimator can be
computed for any value of t, since the baseline probability reflects prevalence, as opposed to an
intensity or occurrence rate.
An alternative estimator of baseline probability π0(t) is given by the empirical estimator π∗0(t) =∑n
i=1 I{Hi(t) = 0, Di > t,Ci ≥ t}I(Zi = 0)/
∑n
i=1 I(Ci ≥ t,Zi = 0) if censoring time Ci is
known or fixed. However, π∗0(t) would generally be less efficient. Moreover, the estimator would
be impossible to compute when few or none of the subjects have covariates at the baseline level,
which would generally be the case in the presence of continuous predictors.
The multiple imputation method we use for unobserved censoring times represents so-called
improper imputation, in the sense that the imputation model parameters are fixed at their estimated
values. For an alternative strategy, proper imputation could also be considered, where the impu-
tation model parameters are drawn from their estimated predictive posterior distribution [Little
and Rubin, 2002]. In such cases, more randomness are introduced to the model since imputation
parameters are drawn instead of being fixed. Both imputation methods would lead to consistent
estimators of covariate effects but, potentially, with slightly different efficiency [Schaubel and Cai,
2006]. The proposed methods are valid under single imputation, M = 1, which would not be
the case under proper imputation. Note that the deterministic variance structures of β̂
1
and π̂10
for single imputation are generally larger than that for multiple imputations β̂
M





1(t, t) > σ
′
M(t, t), for M > 1, which can be proved through the Cauchy-
Schwartz inequality. An intuitive argument is that β̂
M
and π̂M0 are the means of M imputed
estimators, and are generally more efficient than single imputed estimators.
We proposed the Cox (1972) model for imputing censoring times, due to its flexibility and dom-
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inance in the analysis of censored epidemiologic data. Parameters estimated through the proposed
methods are consistent only provided the censoring model is correctly specified. Assumptions
on the censoring model could be assessed through standard techniques, such as Schoenfeld and
Martingale residuals (Kalbfleisch and Prentice [2002]).
A potential problem of our method is that π̂0(t) could be larger than one, for example when
hospitalization and mortality rates are low as we encounter in the real data analysis. In such
cases, it may be useful to model P{Hi(t) = 1 or Di ≤ t|Zi(t)} = 1 − πi(t). Future research
could involve the use of a different link function, such that πi(t) = π0(t)g−1{βT0Zi(t)}, where
g(·) is a continuous function. Note that our method is a special case when g−1(·) is the exponential
function. In particular, choosing g−1(·) as a function mapping from real line to [1,∞), for example
exp(·) + 1, results in π̂0(t) having the desirable property of being bounded by 0 and 1.
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Table 1.4: Analysis of DOPPS Data: Covariate Effects on the Survival-Out-of-Hospital (based on M =
10 Imputations)
Covariate β̂ ŜE(β̂) p exp(β̂)
Age (per 5 years) -0.003 0.001 0.006* 0.997
Time on dialysis (years) -0.023 0.037 0.549 0.977
Height (per 10 cm) 0.009 0.004 0.031* 1.009
Female 0.009 0.008 0.339 1.009
CAD -0.027 0.012 0.042* 0.973
Cancer -0.034 0.015 0.043* 0.966
CVD -0.030 0.016 0.117 0.971
Stroke -0.012 0.018 0.534 0.989
CHF -0.005 0.009 0.547 0.995
Diabetes 0.007 0.006 0.273 1.007
Hypertension 0.001 0.006 0.625 1.001
COPD -0.038 0.021 0.089 0.962
Psychiatric Disorder -0.030 0.017 0.108 0.970
PVD -0.008 0.011 0.422 0.992
Belgium -0.012 0.023 0.609 0.988
Canada -0.010 0.016 0.520 0.990
China -0.007 0.017 0.678 0.993
Gulf -0.016 0.016 0.388 0.984
Germany -0.021 0.016 0.279 0.980
Italy -0.046 0.022 0.046* 0.955
Japan -0.000 0.012 0.807 1.000
Spain 0.003 0.022 0.684 1.003
Sweden -0.008 0.020 0.714 0.992
UK 0.004 0.014 0.498 1.004
a: Coronary artery disease
b: Cardiovascular disease
c: Congestive heart failure
d: Chronic obstructive pulmonary disease
e: Peripheral vascular disease
21
CHAPTER 2
Semiparametric Regression Methods for Temporal
Processes subject to Dependent Censoring
2.1 Introduction
In biomedical applications, the response of interest can often be cast as an binary indicator process
indexed by time. We consider the setting wherein the indicator at time t takes the value 1 (denot-
ing ‘success’ in some form) when the patient is alive and in a particular state, and 0 otherwise.
Examples include the following: (i) In a study of leukaemia patients, the response could be coded
as 1 if the patient is alive and in remission t days following diagnosis, and 0 otherwise. (ii) In a
study of morbidity among end-stage renal disease patients, the response at time t equals 1 if the
patient is alive-and-not-hospitalized at time t, and 0 otherwise. (iii) As another example from the
organ failure setting, an end-stage liver disease (ESLD) patient could be coded as having response
1 if active on the liver transplant waiting list (at time t days after initial wait list registration), and
0 otherwise. When covariate effect are of chief interest, temporal process regression is a natural
way to cast the afore-described data structure. Although several methods amenable to this data
structure have been developed in the last 10-15 years (arguably beginning with the work of Fine
et al. [2004]), relatively few modeling choices are available relative to the frequency with which
this data structure arises in practice. In this report, we develop semiparametric process regression
methods which can be used to model settings such as (i), (ii) and (iii) above, in a flexible manner
and making fewer assumptions regarding the censoring process.
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Formalizing the above-described data structure, suppose that (for a hypothetical subject) D
represents time of death, and E(t) is an indicator taking the value 1 if the subject is in the state
of interest at follow-up time t (and 0 if not). We can define A(t) = E(t)I(D > t), such that the






can be considered a special case of quality adjusted survival time [Gelber et al., 1989, Glasziou
et al., 1990], where ‘quality’ is defined as yes versus no (1 vs. 0). Nonparametric methods [Zhao
and Tsiatis, 1997, Huang and Louis, 1999, Murray and Cole, 2000] and regression methods [Cole
et al., 1993, Laan and Hubbard, 1999, Andrei and Murray, 2007, Zhao and Wang, 2008] have been
proposed to estimate this quality of life measure. In medical cost analysis, if A(t) denotes the
cost at time t, then DA corresponds to the total cost for a patient from the start of treatment to
death without censoring. Lin et al. [1997], Bang and Tsiatis [2000], Willan et al. [2002] focus
on the estimation of mean cost, E(DA). In this report, we do not wish to add to the rich body of
techniques for analyzing more general versions ofDA. Instead, we develop methods for the related
but distinct goal of analyzing the process, E[A(t)].
The methods we propose are motivated by the end-stage liver disease (ESLD) setting. The
preferred therapy for ESLD is deceased-donor liver transplantation. However, due to a shortage of
donor livers, medically suitable patients are placed on a waiting list. A wait-listed patient is eligible
to receive a transplant only when ‘active’; patients may be deactivated for several reasons, most of
which are related to a decline in health status which renders the patient at least temporarily unsuit-
able for transplantation. Hence, keeping the patient active on the wait list represents a successful
outcome, in the sense that the patient not only continues to survive but also remains eligible for
the preferred treatment. A patient’s active process may be censored by liver transplantation, with
such censoring representing dependent censoring due to mutual correlation between A(t) and liver
transplantation. Note that, due to the nature of the liver allocation system in the U.S., a patient’s
rank on the wait list is determined by their Model for End-stage Liver Disease (MELD) score. In
particular, the wait list is sequenced in decreasing order of (current) MELD score. Since higher
MELD scores correspond to higher pre-transplant mortality, a model of pre-transplant outcomes
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based on baseline (time 0) patient characteristics will generally be subject to dependent censoring.
The response we consider could be framed as a temporal process, A(t), where t is continuous.
In contrast to a counting process, A(t) need not be a non-decreasing function. In the context of our
afore-described motivating example, we let A(t) be the indicator of being both alive and active on
the transplant waiting list at time t. In several existing methods developed for temporal process re-
gression, the expectation ofA(t) is linked to linear components through a continuous link function;
for example, Fine et al. [2004], Yan and Fine [2005], Yan and Huang [2009]. This could be viewed
as a generalized linear model indexed by time. The regression coefficients β(t) could be solved
at observed jump points. In our work, we consider a semiparametric model for E[A(t)], where
covariates have multiplicative effects on a completely unspecified probability function indexed by
time.
In this manuscript, we develop semiparametric regression methods for a temporal process sub-
ject to dependent censoring. Two types of censoring are considered. Specifically, we let C1 denote
censoring which is independent conditional on external covariates. Dependent censoring, denoted
by C2, is correlated with the process of interest even given covariates introduced in the process
regression model. To avoid bias due to dependent censoring, we derive a variant of Inverse Proba-
bility of Censoring Weighting (IPCW; Robins and Rotnitzky [1992]) based on a semiparmametric
additive hazard model [Lin and Ying, 1994]. We also derive a stabilized version of the proposed
inverse weights [Hernán et al., 2000, Robins and Finkelstein, 2000, Zhang and Schaubel, 2011] to
simplify calculations and, hence, considerably reduce computing time in large data sets. Analo-
gous to a weighted partial likelihood score equation [Cox, 1972b, Sasieni, 1993], the regression
estimator could be estimated by the solution to an estimating equation free of the baseline proba-
bility.
Our methods have several novel features. First, the baseline probability function is represented
in the model nonparametrically. This is a potentially big advantage, since covariate effects typically
take center stage in process regression (and other regression settings), with little interest in mod-
eling the baseline probability. We essentially profile out the baseline probability function, which
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results in major computation reduction relative to a fully parametric probability model. Second,
the response indicator we consider is the joint event of survival and state occupation. The limited
number of process regression methods which considered a terminating event typically modeled the
state indicator conditional on survival. Notwithstanding the utility of such approaches, it is useful
to develop methods for the joint outcome of survival and state occupation (a response for which
few methods have been developed). Third, existing process regression methods typically assume
independent censoring, while the proposed methods allow for both independent and dependent
censoring. Fourth, in contrast with the vast majority of methods which accommodate dependent
censoring, we construct the inverse weight under an additive hazards model.
The remainder of the article is organized as follows. We set up notation and describe our
proposed methods in the next section. In Section 3, we derive the asymptotic properties of the
regression parameter estimator and baseline probability function estimator, with proofs provided
in the Supplemental Materials document. Simulation studies are performed to evaluate our method
in finite samples in Section 4 under various scenarios. In Section 5, we apply the proposed methods
to national ESLD data. Finally, concluding remarks are given in Section 6.
2.2 Model and Methods
We begin by formalizing the data structure described in Section 1. We then describe the proposed
inference methods.
2.2.1 Notation and Assumed Models
Suppose that there are n independent subjects (i = 1, 2, . . . , n). Let Di be the death (terminal
event) time of subject i, and let Ei(t) be a indicator function taking value 1 when subject i is
occupying the state of interest at follow-up time t. The outcome of interest is the joint event, being
alive and occupying the state of interest, which we denote by Ai(t) = Ei(t)I(Di > t). In the end-
stage liver disease example, Di represents death (in the absence of liver transplantation), while
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Ei(t) = 1 if subject i is active on the liver transplant waiting list as of t days following initial wait
list registration, and 0 otherwise. We let Zi(t) be a p-dimensional covariate vector, with any time-
dependent elements being external [Kalbfleisch and Prentice, 2002]. The probability of interest is
the probability that a subject i is alive and occupying the state of interest at time t,
πi(t) = P [Ai(t) = 1|Zi(t)]. (2.1)
We assume that the covariateZi(t) has a multiplicative effect on a completely unspecified baseline
probability function, π0(t), such that
πi(t) = π0(t)exp[βT0Zi(t)], (2.2)
where β0 is the p-dimensional parameter vector of chief interest. Model (2.2) is reminiscent of
the Cox proportional hazards model. However, there are some important differences, including the
fact that πi(t) is interpreted as a marginal probability, rather than a conditional probability rate,
and that πi(t) need not be monotone.
Two types of censoring are considered. Let C1i be the administrative censoring, which is
assumed to be independent of Ai(t) given Zi(t); i.e.,
E[Ai(t)|Zi(t), C1i, C1i ≥ t] = E[Ai(t)|Zi(t)]. (2.3)
This is also known as covariate-dependent censoring, in the sense that C1i is allowed to depend on
the covariate employed in the model of interest. We let C2i represent dependent censoring time;
that is, C2i is not assumed to be conditionally independent Ai(t) given Zi(t). For example, in the
context of our motivating example, a patient’s pre-transplant Ai(t) process is censored if and when
the patient receives a liver transplant; i.e., the liver transplant hazard and mortality hazard may be
correlated, even conditional on Zi(t). We let Ci = C1i ∧ C2i represent the censoring time, where
a ∧ b = min(a, b). Here we consider follow-up time t ∈ [0, τ ], where τ is a pre-specified constant
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satisfying Pr(Ci ≥ τ) > 0 for i = 1, 2, ..., n. In practice, τ could be chosen as the maximum
observed censoring time. To further characterize C2i, we let X
†
i (t) represent the time-dependent
covariate at time t. Note that X†i (t) would typically contain the elements of Zi(t), as well as
additional factors (the most important being internal time-varying covariates assumed to predict
both Di and C2i). We denote the covariate history as of time t by X̃ i(t) = {X†i (s), s ∈ [0, t)}.
Finally, we let λC2i (t) be the cause specific hazard function of C2i which is defined as




Pr[t ≤ C2i < t+ δ|C2i ≥ t,Di ≥ t, X̃ i(t)]. (2.4)
We assume that, conditional on X̃ i(t), the cause-specific hazard of C2i at time t does not further
depend on the possibly unobserved, Di or Ei(u), s ∈ (t, τ ], i.e.,
λCi {t|X̃ i(t)} = λCi {t|X̃ i(t), C1i, C1i ≥ t,Di, Di ≥ t, Ei(u), u ∈ (t, τ ]}. (2.5)
This represents the critical ‘no unmeasured confounders‘ for censoring assumption [Robins, 1993,
Robins and Finkelstein, 2000] in our context. The following semiparametric additive hazards
model [Lin and Ying, 1994] is assumed for dependent censoring C2i,
λC2i (t;θ0) = λ
C2
0 (t) + θ
T
0X i(t), (2.6)
where λC20 (t) is the baseline hazard function forC2i and the covariateX i(t) is chosen (e.g., through
model selection techniques) to satisfy λC2i [t|X i(t)] = λ
C2
i [t|X̃ i(t)]. Note that X i(t) need not be
based on the covariate status at time t and could, in fact, contain elements representing the covariate
history. Finally, we define ΛC2i (t) =
∫ t
0
λC2i (s)ds as the cumulative hazard function corresponding
to C2i.
The additive hazards model stated in (2.6) facilitates the calculation of the weight function,
since the baseline cumulative hazard function can be canceled out after a particular stabilizing
factor introduced. Detail is provided later in our report on this matter.
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In the next subsection, we describe the proposed methods for the scenario where independent
censoring time C1 is known. We then subsequently describe the proposed techniques for the more
frequently occurring set-up when C1 is not known.
2.2.2 Known Censoring Time
We first consider the case where the independent censoring time, C1i, is known for all subjects. In
such cases, C1i is known even if Di occurs first. This set-up would apply, for example, in a clinical
trial with staggered entry but no drop-out or random loss to follow-up. This does not match most
observational data, but it is a useful starting point in terms of outlining the proposed estimation





Zi(t)[Ai(t)− πi(t)]I(Ci ≥ t)dt (2.7)
n∑
i=1
[Ai(t)− πi(t)]I(Ci ≥ t). (2.8)
These two estimating equations do not have expectation zero under model assumption (2.2) and
conditionally independent censoring assumption (2.3) of C1i, since dependent censoring C2i is
potentially correlated with Ai(t), even conditional on Zi(t). To handle this issue, we utilize In-
verse Probability of Censoring Weighting (IPCW) [Robins and Rotnitzky, 1992] to accommodate
dependent censoring. Define
WAi (t;θ0) = I(C2i ≥ t)exp{Λ
C2
i [t ∧Di;θ0]} (2.9)
as, heuristically, the inverse probability of being uncensored by C2i as of time t. Note that, in the
data structure we consider, dependent censoring cannot occur after death. This make sense intu-
itively, from the perspective that C2i is driven by internal factors (including a subject’s survival).
For instance, in our motivating example, a patient cannot receive a liver transplant after dying.
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Zi(t)[Ai(t)− πi(t)]I(C1i ≥ t)WAi (t;θ0)dt (2.10)
n∑
i=1
[Ai(t)− πi(t)]I(C1i ≥ t)WAi (t;θ0). (2.11)
Under the no-unmeasured-confounders assumption given in (2.5), these two weighted estimat-
ing equations have expectation zero. Basically, the proof follows from the fact that WAi (t;θ0)
can be written as one minus a Martingale component of C2i, which is independent of [Ai(t) −
πi(t)]I(C1i ≥ t) conditional onX i(t) [Robins and Finkelstein, 2000]. Detailed proof are provided
in the Section 4.6 of Supplemental Materials.
In contrast to the majority of the existing literature, we derive a stabilizer that is merely a
function of t, which is valid since E{g(t)[Ai(t) − πi(t)]I(C1i ≥ t)WAi (t;θ0)|Zi(t)} = 0 will
hold. We denote g(t) = exp[−
∫ t∧Di
0
dΛC20 (s;θ0)] for this purpose, such that












ΛC20 (t) cancels out. This nice property enables us to get unbiased estimating equations without
estimating the baseline cumulative hazard ΛC20 (t) and, hence, should increase computational effi-
ciency.
Solving (2.11) for π0(t) by treating β as known, then substituting the estimated π0(t) into





{Zi(t)− Z̄[t;β,W (θ0)]}I(C1i ≥ t)Wi(t;θ0)dt = 0, (2.13)




t)Wi(t;θ)exp{βTZi(t)}, for k = 0, 1, 2, where a⊗0 = 1, a⊗1 = a, and a⊗2 = aaT , and with
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Wi(t;θ) set to either WAi (t;θ) or W
B
i (t;θ), depending on which is preferred for the application at
hand. Having estimated β0 through the root of equation (2.13), denoted by β̂, we could estimate













which could be interpreted as the restricted mean time survived in the state of interest for subject





Based on model (2.6), one could estimate θ0 and ΛC2i (t;θ0) by θ̂ and Λ̂
C2
i (t; θ̂). From the





















where NC2i (t) = I(C2i ≤ t ∧Xi), dN
C2
i (t) = N
C2
i (t
− + dt) − NC2i (t−), Yi(t) = I(Xi ≥ t) and
Xi = Di ∧ Ci. Let X(k)(t) = n−1
∑n
i=1X i(t)
⊗kYi(t), X̄(t) = X(1)(t)/X(0)(t). After that, the
estimated weights ŴAi (t; θ̂) or Ŵ
B
i (t; θ̂) can be calculated.
2.2.3 Random Censoring Time
Next we consider a more realistic scenario where independent censoring time is random, with the
randomness implying that C1i is unknown when Di occurs first. Setting the missing censoring
time to either Di or the maximum follow up time, τ , would introduce bias, since the indicator
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I(C1i > Di) is correlated with the target process. As for C2i, if Di happens first, then C2i could be
treated as infinity or considered to be subject to a dependent censoring hazard of 0 for t > Di. The
reason is that C2i relies on time varying covariate vector X i containing internal covariates, which
would shut down if death occurs. In this case, the hazard for C2i is zero after Di. Moreover, the
inverse weighting function Wi(t;θ0) remains constant after Di if it is observed earlier than Ci.
Our solution is to impute missing C1i from its assumed model [Rubin, 2004]. Specifically, we
assume it follows the proportional hazards model





For subjects with Ci ≤ Di, we set the imputed censoring time as the known censoring time. In the
mth imputed dataset, for subjects with Ci > Di, we impute Ĉ
〈m〉
1i from the estimated conditional
survival function,
Ĝ(t; γ̂) = I(t ≥ Di)exp[−Λ̂C1i (t; γ̂) + Λ̂
C1
i (Di; γ̂)].
Standard partial likelihood [Cox, 1975] techniques can be fitted to the observed censoring time
data {Xi, I(C1i ≤ Di ∧ C2i),Zi(t); t ∈ [0, τ ]}ni=1 to compute γ̂. The baseline cumulative
hazard function for ΛC10 (t) is estimated through the method of Breslow [1972]. Then, we set
C
〈m〉
1i = I(Ci ≤ Di)Ci + I(Ci > Di)Ĉ
〈m〉
1i . In total we will create M imputation datasets. Within
each imputed datasetm, we substitute C〈m〉1i for C1i and set C2i as τ ifDi < C1i. Estimators arising
from the mth imputed data set are denoted by β̂
〈m〉
and π̂〈m〉0 (t). We then estimate β0 and π0(t) by
























Note that the multiple imputation method we employ does not sample the parameters assumed
to underly the C1 distribution but, instead, imputes C
〈m〉
1i values from the same estimated survival
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curve. This procedure has been referred to as Improper Imputation [Wang and Robins, 1998]. As a
consequence of this choice, the well-established variance formula for multiple imputation [Rubin,
2004] does not apply, necessitating an explicit derivation of variances estimators corresponding to
(2.19) and (2.20). These issues are dealt with in the next section, along with our treatment of the
large-sample properties of the proposed estimators.
Some commentary regarding our combination of inverse weighting and imputation is useful
at this juncture. The sources of censoring, C1 and C2, have very different implications in terms
of their impact on parameter estimation. Due to the marginal nature of πi(t), subjects contribute
relevant follow-up until time C1i, which may occur after Di. A similar issue arises in Gray [1988]
and Fine and Gray [1999] in the context of inference targeting the subdistribution hazard function
in the competing risks setting. Both Gray [1988] and Fine and Gray [1999] used a weight function,
rather then imputation. It is important to note that the weight was not an inverse weight; if anything,
it could be described as an ‘inverse-inverse’ weight, since it corresponds to a conditional survival
probability (as opposed to the inverse thereof). Essentially, the risk sets contributions are weighted
with respect the conditional probability of remaining uncensored at time t (consider t > Di), given
that Ci1 > Di. From this perspective, imputing C1i does in fact appear consistent in spirit with
the weights use in subdistribution modeling, which can be cast heuristically as mean imputation
at the risk set level. In fact, Ruan and Gray [2008] later proposed subdistribution hazard methods
which involved imputing censoring times. An analogous imputation scheme was later employed
by Schaubel and Zhang [2010].
Note that C1i marks the end of relevant follow-up and, hence, is a variate we want to observe.
Provided we either observe C1i or can validly impute its value, the [0, C1i] experience could be
analyzed without inverse weighting if not for dependent censoring, C2i. In line with the setting
where IPCW is typically employed, we inverse weight the uncensored experience to reflect data
that would have been observed if C1i were the only source of censoring. The events Di and C2i
serve as competing risks in the sense of Prentice et al. [1978]. From this angle, dependent censoring
does not occur after Di, hence the weight function not incrementing for t > Di, per (2.9).
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2.3 Asymptotic Properties
We begin by considering the case where independent censoring time C1 is known. The large
sample properties are provided for the weight, WBi (t;θ0) = exp[
∫ t∧Di
0
θT0X i(s)ds], with results
for WAi (t;θ0) given in the Supplemental Materials. In addition to the regularity conditions for
proportional hazards model of C1i and additive hazards model of C2i (each provided in the Section
3 of Supplemental Materials), we also assume the following set of regularity conditions:
(a) {Ai(t), Xi,Zi(t),X i(t), I(C1i ≤ Di∧C2i), I(C2i ≤ Di∧C1i); t ∈ [0, Xi]} are independent
and identically distributed for i = 1, 2, . . . , n.




|dZij(t)| < cZ <∞ almost surely for i = 1, 2, ..., n, j = 1, 2, ..., p; i.e.,Zi(t)
has bounded total variation.
(d) Ω(β0,W ) = E[
∫ τ
0
{z(2)(t;β0,W )/z(0)(t;β0,W ) − z̄(t;β0,W )⊗2}I(C1 ≥ t)A1(t)dt] is
positive definite.
(e) For β ∈ Bδ, where Bδ is a small neighborhood around β0, z(0)(t;β,W ), and z(1)(t;β,W )
are bounded away from zero.
(f) For β ∈ Bδ, k = 0, 1, 2, z(k)(t;β,W ) are continuous uniformly on t ∈ [0, τ ], and are
bounded on [0, τ ]×Bδ for WA(θ0) and WB(θ0).
We summarize the essential large sample properties of β̂ and π̂0(t) in the following theorems.
Proofs are sketched in the Supplemental Materials.
Theorem 5. Under assumptions (2.2), (2.3), and (2.5), β̂ is a consistent estimator of β0, and
n1/2(β̂ − β0) converges in distribution to a mean-zero normal random variable with a variance-
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i (θ,β) = Ω[β,W
B(θ)]−1[Φ
βB











2i (θ,β) = H
B[β,θ,WB(θ)][ΩC2 ]−1uC2i (θ).
Here [ΩC2 ]−1uC2i (θ0) is the influence function for additive hazard model of C2i, and is de-
fined in the Supplemental Materials along with dMi(t;β) and HB[β,θ,W ]. The variance es-





⊗2 could be obtained by substituting limiting values in
Σ(θ0,β0) by their corresponding empirical counterparts. However, the computation of Σ̂(θ̂, β̂)
are tedious due to the complexity of Φ̂
βB
2i (θ̂, β̂). An attractive alternative is to treat estimated











{Zi(t) − Z̄[t;β, ŴB(θ)]}ŴBi (t;θ)dM̂i(t;β). In this case, the proposed vari-
ance estimator will be conservative in estimating the true variance [Hernán et al., 2000, Pan and
Schaubel, 2008, Zhang and Schaubel, 2011].
We now describe the asymptotic properties of π̂0(t).
Theorem 6. Under assumptions (2.2), (2.3), and (2.5), n1/2(π̂0−π0) converges weakly to a mean-
zero Gaussian process with a variance and covariance matrix between n1/2[π̂0(s) − π0(s)] and
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f̃π1,Bi (t,θ) = f̃
π11,B
i (t,θ) + f̃
π12,B
i (t,θ)
f̃π11,Bi (t,θ) = I(C1i ≥ t)Ai(t)WBi (t;θ)





f̃π2,Bi (t,θ,β) = f̃
π21,B
i (t,θ,β) + f̃
π22,B
i (t,θ,β) + f̃
π23,B
i (t,θ,β)
f̃π21,Bi (t,θ,β) = I(C1i ≥ t)eβ
TZi(t)WBi (t;θ)










Similar to the calculation of Σ̂(θ̂, β̂), we also treat the estimated weights function as fixed.
Therefore, the variance estimator σ̂(s, t, θ̂, β̂) is calculated by estimating f̃π1,Bi (t,θ0) by f̂
π11,B
i (t, θ̂),
and f̃π2,Bi (t,θ0,β0) by f̂
π21,B
i (t, θ̂, β̂), where f̂
π11,B





Next we consider the scenario where C1i is not known for all i, with M imputed censoring
times used for subjects where C1i is not observed.
Theorem 7. Under assumptions (2.2), (2.3), (2.5) and (2.18) β̂
M




− β0) converges in distribution to a mean-zero normal random variable with a






i (θ,β,γ,M) = Ω[β,W
B(θ)]−1[Φ
βB
























1i ≥ t;γ)I(C2i ≥ t)dt.
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Note that ΦβB2i (θ,β) is the same as defined in Theorem 1.
For πM0 (t), we have the following result.
Theorem 8. Under assumptions (2.2), (2.3), (2.5) and (2.18), n1/2(π̂M0 − π0) converges weakly to
a mean-zero Gaussian process with a variance and covariance matrix between n1/2[π̂M0 (s)−π0(s)]









f̃π2,Bi (t,θ,β,γ,M) = f̃
π21,B
i (t,θ,β,γ,M) + f̃
π22,B










1i ≥ t;γ)I(C2i ≥ t)eβ
TZi(t)WBi (t;θ)




Similar to the known censoring case, the variance could be estimated by its empirical counter-
part and by treating weight function as known.
2.4 Simulation Studies
We report on simulations to evaluate performance of our methods. The results of three weights
are evaluated: Wi(t) = 1, which does not correctly accommodate the censoring mechanisms and
is included for comparison purposes only; WAi (t;θ0) defined in (2.9); and the stabilized weights,
WBi (t;θ0), defined in (2.12).
For each simulation setting, two scenarios (n = 300, n = 500) are generated. The covariate
Z = (Z1, Z2)
′ has elements which are Bernoulli(0.5). The terminal event, D, is generated by
the hazard function λD0 exp{αT0Z}, where λD0 = 0.02 and α0 = (−0.609, 0.609)T . The target
model represents the probability of being alive and active, π(t) = π0(t)exp{βT0Z}, where π0(t) =
0.3 − 0.0025t, for t = 1, 2, ..., 100. The event of being active on waiting list given the subject is
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alive is sampled from the conditional probability, P{E(t) = 1|D > t,Z} = π(t)exp[λD × t].
We generated two censoring times, C1 and C2, for each individual. The independent cen-
soring time, C1, is generated from the hazard function λC0 exp{γT0Z}, where λC0 = 0.015 and
γ0 = (0.609,−0.609)T . For the dependent censoring time, C2, we first generate Xt, where
Xt = min{D,−40 × log[Z1ε1 + (1 − Z2)(1 − ε1)] + 5ε2}, ε1 =
∫ 100
1
A(t)dt/100 , ε2 ∼ Uni-
form(0,1). Let X(t) = I(Xt ≥ t), with X(t) being dependent on A(t) even conditional on Z due
to its mutual association with ε1. Next, we generate time-dependent censoring time C2 from the
hazard function λC0 + φ1Z1 + φ2Z2 + φ3X(t). Note that ε1 and ε2 are mutually independent.
In Table 2.1, we consider the setting wherein C1 is known. We set λC0 = 0.006, φ1 = φ2 =
−0.002, and φ3 = 0.035 for heavy censoring C2, which results in about 53% subjects being
censored by C2 and 37% subjects censored by C1. Moreover, two magnitudes of β0 are con-
sidered: 0.916 and 0.405. Next we consider a light censoring case for C2, where λC0 = 0.003,
φ1 = φ2 = −0.001, and φ3 = 0.015. This set-up results in 33% subjects are censoring be C2 and
48% subjects are censoring be C1. In Table 2.2 we treat censoring time as random, and get imputed
estimators from M = 1 imputation dataset.
In each setting, the biases of β̂ and Π̂0(50) are very small for both ŴAi (t; θ̂) and Ŵ
B
i (t; θ̂),
indicating that our estimators are consistent. Moreover, empirical standard deviations (ESDs) are
generally close to, but larger than the average asymptotic standard errors (ASEs), because we
treat the estimated weights function as fixed. The empirical coverage probabilities (ECPs) are
also around 0.95, implying the accuracy of large-sample confidence intervals. Due the substantial
biases of not adjusting time dependent confounder, the unweighted method exhibits bias and has
inaccurate estimated variance and poor coverage probabilities.
2.5 Real Data Analysis
We applied the proposed methods to model the wait list active/inactive process using data ob-
tained from the Scientific Registry of Transplant Recipients (SRTR). In the end-stage liver disease
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(ESLD) setting, the number of available deceased-donor livers is always less than the number of
patients in need of liver transplantation. Once an ESLD patient is wait listed, the patient’s status
can oscillate between active and inactive based on their medical condition. A wait listed patient can
receive deceased-donor organ offers only when active. To date, there has been little study of the
probability of remaining active on the wait list, for ESLD or any type of end-stage organ failure.
The sample size of this study is n = 53, 991. Patients are subject to independent right censoring
due to administrative censoring and living donor transplantation. Note that living-donor transplants
are not allocated using the MELD system and, as such, are not determined by internal time-varying
covariates. In contrast, deceased-donor transplantation is viewed as dependent censoring, since
the transplant hazard and pre-transplant mortality hazard are correlated with time-varying MELD
score. Therefore, deceased-donor transplantation is viewed as dependent censoring, while other
causes of censoring are aggregated into C1. Based on this classification, there were 13,180 subjects
observed to die, 17,982 patients who were independently censored, and 22,829 subjects who were
dependently censored. The median observation time is 201 days, while the median time spent in
the active state is 160 days.
Baseline covariates include blood type, gender, race, BMI status, hospitalization, age, region,
and values at wait listing for MELD score, serum albumin and serum sodium. Comorbid condi-
tions are also included, for example hepatitis C, noncholestatic, cholestatic, acute hepatic necrosis,
metastatic disease, malignant neoplasm. The covariate information at time zero are used to charac-
terize the process of being alive and active on waiting list, and to implement the imputation of C1.
As for time dependent covariates, we include more predictors to the baseline covariates set: MELD
all score, albumin levels, sodium, ascites, encephalitis, and dialysis status, and exclude baseline
MELD, baseline albumin and baseline sodium. Moreover, continuous variables are centered at
their mean values.
The stabilized weights, WB(t;θ), were used to remove bias due to dependent censoring. To
further mitigate the impact of outliers, the weights were capped by 150. For subjects with observed
death, we imputed C1 as describe in Section 2.2. Due to the size of the data set, we used M = 1.
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Covariate effects along with p values are listed in Table 2.3. Among the diagnoses leading
ESLD, acute hepatic necrosis was associated with a significant 12% increase in probability of
being alive and active on the waiting list. Patients with ESLD resulting from malignant neoplasm
experienced an 11% reduction in survival/active probability (p = 0.01). Obesity (i.e., BMI ≥30)
was associated with a significant 5% reduction. Being hospitalized in the ICU at the time of wait
listing was associated with an 18% increase (p = 0.001) in the alive/active probability, relative to
not being hospitalized. Each 5-year increase in age at wait listing was associated with a significant
2% decrease in alive/active probability. Relative to the United Network for Organ Sharing (UNOS)
Region with the greatest number of wait listed patients (Region 5), Region 1, 10 and 11 had
significant reductions in alive/active probability, at 17%, 6%, and 16%, respectively. Region 7
had a 6% increase (p = 0.01). The probability of being alive and active on the wait list decreased
with by 1% for each (integer) increase in MELD score, and increased by 9% per unit increase in
serum albumin. We provide some interpretation of these results in Section 2.6.
The estimated baseline probability function is plotted in Figure 2.1. We estimated the integral
of baseline probability of being alive and active over [0, 5] at 3.92 years; this indicates that a
‘baseline’ patient (i.e., patient with all covariates equal to the reference) would be expected to be
alive and active on the wait list for ≈4 of the first 5 years after wait listing, in the absence of liver
transplantation.
2.6 Concluding Remarks
In this article, we propose semiparametric temporal process regression methods. Relative to exist-
ing process regression methods, our methods are distinguished by several features. In particular,
the baseline probability (as a function of time) is unspecified and is essentially profiled out in the
estimation of the regression coefficient (presumably of chief interest in most studies). The method
accommodates dependent right censoring, and does so through a computationally attractive addi-
tive hazards model. In our context, the additive hazard model facilities the calculation of weight
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function, since the baseline cumulative hazard function cancels out. Moreover, the proposed meth-
ods accommodate independent right censoring through imputation rather than a weight function.
We applied our proposed methods to the analysis of factors affecting the joint probability of
being alive and active on the liver transplant waiting list. There are many reports in the literature
regarding the factors affecting pre-liver transplant survival. The analysis we present in Section 2.5
is among the first to incorporate active/inactive status into the end-point. Survival in the absence
of liver transplantation is, in its own right, an important process in the context of end-stage liver
disease. Part of its importance derives from the fact that the preferred treatment for ESLD, liver
transplantation, does not occur without the patient surviving long enough on the wait list to receive
offers. However, survival on the wait list is not enough, since only a patient can only receive offers
while active.
Our analysis revealed several factors as being significantly associated with the probability of
being alive/active. Model of End-stage Liver Disease score is the basis of deceased-donor liver
allocation among chronic ESLD patients, so its effect is not surprising. Serum albumin is a marker
of nutritional status, and have been shown in several previous reports to be predictive of pre-
transplant survival. The appearance that being hospitalized in the intensive care unit is possible
due to selection bias. It is possible that sicker patients in the ICU die before having the opportunity
to be wait listed. Or, the wait listing of such patients may sometimes deliberately not be pursued,
in order to avoid futile transplantation. We do not have data to further evaluate either hypothesis.
The differences in active/survival probability by UNOS Region may be due to differences in pre-
transplant survival and/or discrepancies in deactivation protocols. Such differences are worthy of
future investigation.
Our methods make the distinction between independent censoring, C1, and dependent cen-
soring, C2. This is necessary since the variates play very different roles in our framework. C1
represent the end of a subject’s potential follow-up. This is the case in several existing methods,
including the popular subdistribution hazard modeling of Fine and Gray (1999). The methods of
Fine and Gray (1999) do not impute unobserved C1 but, instead, apply a weight function which
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Figure 2.1: Estimated Baseline Probability of being Active and Alive
represent the conditional probability of being uncensored (given that the subject was uncensored
at the time of death). This weight function is essentially playing the same role as our imputation of
C1. In contrast, C2 is a nuisance process, with its corresponding inverse weight seeking to recover
the data that would be observed if the process underling C2 were absent.
In our framework, we assume additive hazards model [Lin and Ying, 1994] on dependent cen-
soring time, which is a practical alternative to the proportional hazards model. These two models
will normally provide adequate fit to data if appropriate time-dependent covariates are included.
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Table 2.1: Simulations Results for Known Censoring Time based on 500 Replicates
β̂
Censoring n β0 Weights Bias ASE ESD CP
Heavy 500 (0.916, -0.916) 1 (0.183, -0.125) (0.095, 0.096) (0.098, 0.095) (0.520, 0.764)
WA (0.000, 0.008) (0.134, 0.134) (0.149, 0.146) (0.908, 0.928)
WB (0.025, -0.010) (0.119, 0.119) (0.127, 0.128) (0.932, 0.932)
(0.405, -0.405) 1 (0.191, -0.132) (0.095, 0.095) (0.099, 0.090) (0.480, 0.738)
WA (0.031, 0.000) (0.141, 0.140) (0.157, 0.158) (0.900, 0.926)
WB (0.037, -0.022) (0.123, 0.124) (0.130, 0.122) (0.918, 0.944)
1000 (0.916, -0.916) 1 (0.187, -0.129) (0.068, 0.068) (0.066, 0.067) (0.204, 0.536)
WA (0.001, 0.016) (0.100, 0.100) (0.104, 0.110) (0.936, 0.926)
WB (0.024, -0.014) (0.087, 0.087) (0.088, 0.096) (0.936, 0.934)
(0.405, -0.405) 1 (0.187, -0.123) (0.068, 0.068) (0.068, 0.071) (0.218, 0.544)
WA (0.025, -0.007) (0.101, 0.102) (0.111, 0.112) (0.918, 0.906)
WB (0.036, -0.020) (0.091, 0.091) (0.094, 0.091) (0.912, 0.940)
Light 500 (0.916, -0.916) 1 (0.103, -0.059) (0.089, 0.089) (0.092, 0.090) (0.776, 0.896)
WA (-0.003, 0.006) (0.104, 0.104) (0.103, 0.103) (0.948, 0.952)
WB (0.011, 0.001) (0.098, 0.098) (0.097, 0.097) (0.960, 0.962)
(0.405, -0.405) 1 (0.115, -0.075) (0.090, 0.090) (0.090, 0.099) (0.750, 0.838)
WA (0.006, -0.009) (0.107, 0.108) (0.114, 0.105) (0.928, 0.960)
WB (0.017, -0.017) (0.100, 0.100) (0.098, 0.103) (0.952, 0.936)
1000 (0.916, -0.916) 1 (0.100, -0.058) (0.063, 0.063) (0.063, 0.064) (0.654, 0.844)
WA (-0.005, 0.017) (0.074, 0.074) (0.071, 0.072) (0.966, 0.952)
WB (0.008, -0.003) (0.069, 0.069) (0.067, 0.069) (0.946, 0.946)
(0.405, -0.405) 1 (0.107, -0.068) (0.064, 0.064) (0.064, 0.066) (0.624, 0.816)
WA (0.011, -0.006) (0.076, 0.076) (0.078, 0.078) (0.920, 0.950)
WB (0.019, -0.015) (0.072, 0.072) (0.071, 0.074) (0.932, 0.928)
Π̂0(50)
Censoring Π0(50) n β0 Weights Bias ASE ESD CP
Heavy 11.812 500 (0.916, -0.916) 1 -2.182 0.849 0.843 0.280
WA 0.258 1.321 1.368 0.920
WB -0.364 1.170 1.219 0.896
(0.405, -0.405) 1 -2.247 0.854 0.831 0.258
WA 0.096 1.316 1.349 0.944
WB -0.400 1.169 1.197 0.904
1000 (0.916, -0.916) 1 -2.202 0.607 0.597 0.070
WA 0.185 0.946 0.895 0.954
WB -0.347 0.844 0.838 0.900
(0.405, -0.405) 1 -2.248 0.609 0.621 0.058
WA 0.154 0.945 0.929 0.954
WB -0.369 0.842 0.831 0.924
Light 11.812 500 (0.916, -0.916) 1 -1.107 0.858 0.864 0.718
WA 0.215 1.023 0.992 0.946
WB -0.140 0.956 0.972 0.934
(0.405, -0.405) 1 -1.113 0.859 0.863 0.726
WA 0.275 1.020 1.026 0.938
WB 0.011 0.967 0.931 0.962
1000 (0.916, -0.916) 1 -1.125 0.605 0.629 0.550
WA 0.172 0.714 0.676 0.960
WB -0.073 0.680 0.682 0.950
(0.405, -0.405) 1 -1.094 0.611 0.630 0.554
WA 0.191 0.715 0.727 0.930
WB -0.059 0.681 0.649 0.950
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Table 2.2: Simulations Results for Random Censoring Time based on M = 1, and 500 Replicates
β̂
1
Censoring n β0 Weights Bias ASE ESD CP
Heavy 500 (0.916, -0.916) 1 (0.190, -0.141) (0.096, 0.096) (0.092, 0.093) (0.472, 0.718)
WA (0.011, -0.004) (0.137, 0.135) (0.136, 0.146) (0.968, 0.936)
WB (0.028, -0.023) (0.122, 0.121) (0.123, 0.123) (0.938, 0.952)
(0.405, -0.405) 1 (0.194, -0.136) (0.096, 0.096) (0.093, 0.098) (0.484, 0.678)
WA (0.036, -0.019) (0.142, 0.142) (0.151, 0.155) (0.914, 0.930)
WB (0.042, -0.040) (0.124, 0.124) (0.129, 0.127) (0.912, 0.934)
1000 (0.916, -0.916) 1 (0.191, -0.132) (0.069, 0.069) (0.069, 0.067) (0.186, 0.518)
WA (0.000, 0.005) (0.102, 0.101) (0.095, 0.107) (0.964, 0.944)
WB (0.020, -0.014) (0.088, 0.088) (0.085, 0.088) (0.940, 0.942)
(0.405, -0.405) 1 (0.189, -0.137) (0.069, 0.068) (0.068, 0.067) (0.194, 0.494)
WA (0.024, -0.019) (0.104, 0.105) (0.104, 0.108) (0.924, 0.928)
WB (0.037, -0.034) (0.092, 0.092) (0.092, 0.094) (0.902, 0.904)
Light 500 (0.916, -0.916) 1 (0.098, -0.055) (0.090, 0.089) (0.088, 0.084) (0.818, 0.926)
WA (-0.007, 0.008) (0.103, 0.104) (0.100, 0.100) (0.960, 0.958)
WB (0.000, 0.000) (0.098, 0.098) (0.097, 0.094) (0.956, 0.954)
(0.405, -0.405) 1 (0.114, -0.065) (0.091, 0.090) (0.090, 0.088) (0.764, 0.896)
WA (0.010, -0.008) (0.107, 0.107) (0.103, 0.111) (0.962, 0.936)
WB (0.031, -0.032) (0.101, 0.101) (0.095, 0.097) (0.950, 0.934)
1000 (0.916, -0.916) 1 (0.100, -0.060) (0.064, 0.063) (0.063, 0.063) (0.676, 0.860)
WA (-0.008, 0.014) (0.074, 0.074) (0.071, 0.073) (0.952, 0.948)
WB (0.002, -0.001) (0.070, 0.070) (0.070, 0.066) (0.944, 0.956)
(0.405, -0.405) 1 (0.110, -0.074) (0.065, 0.064) (0.064, 0.062) (0.608, 0.814)
WA (0.015, -0.009) (0.077, 0.077) (0.075, 0.071) (0.934, 0.956)
WB (0.023, -0.021) (0.072, 0.073) (0.074, 0.073) (0.930, 0.932)
Π̂10(50)
Censoring Π0(50) n β0 Weights Bias ASE ESD CP
Heavy 11.812 500 (0.916, -0.916) 1 -2.304 0.847 0.820 0.244
WA 0.082 1.351 1.199 0.980
WB -0.483 1.179 1.100 0.918
(0.405, -0.405) 1 -2.401 0.846 0.843 0.204
WA -0.012 1.335 1.260 0.948
WB -0.478 1.178 1.100 0.922
1000 (0.916, -0.916) 1 -2.362 0.602 0.605 0.038
WA 0.020 0.953 0.855 0.958
WB -0.458 0.837 0.811 0.904
(0.405, -0.405) 1 -2.368 0.604 0.601 0.038
WA 0.010 0.942 0.923 0.948
WB -0.476 0.839 0.837 0.912
Light 11.812 500 (0.916, -0.916) 1 -1.182 0.851 0.848 0.706
WA 0.182 1.012 0.954 0.952
WB -0.150 0.955 0.994 0.936
(0.405, -0.405) 1 -1.234 0.849 0.826 0.666
WA 0.147 1.008 1.002 0.948
WB -0.219 0.959 0.904 0.932
1000 (0.916, -0.916) 1 -1.202 0.603 0.585 0.502
WA 0.087 0.715 0.664 0.962
WB -0.156 0.679 0.662 0.942
(0.405, -0.405) 1 -1.176 0.608 0.576 0.506
WA 0.064 0.715 0.668 0.960
WB -0.168 0.678 0.682 0.952
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Table 2.3: Analysis of Liver Transplant Data: Covariate Effects on being Active on the Waiting
List and being Alive (based on M = 1 Imputation)
Covariate Value β̂ ŜE(β̂) p exp(β̂)
Blood type (v.s. O) A 0.0113 0.0140 0.421 1.01
AB -0.0057 0.0390 0.8843 0.99
B 0.0160 0.0202 0.4265 1.02
Gender Female 0.0234 0.0131 0.0748 1.02
Race (v.s. White) Black 0.0036 0.0257 0.8898 1.00
Hispanic 0.0266 0.0182 0.1441 1.03
Asian 0.0284 0.0291 0.3287 1.023
Other -0.0396 0.0698 0.5707 0.96
Diagnosis HCV -0.0245 0.0215 0.2544 0.98
Noncholestatic 0.0388 0.0204 0.0568 1.04
Cholestatic 0.0450 0.0256 0.0792 1.05
Acute hepatic necrosis 0.1116 0.0429 0.0094* 1.12
Metastatic disease 0.0246 0.0500 0.6229 1.03
Malignant neoplasm -0.1130 0.0464 0.0149* 0.89
BMI (v.s. (20, 25)) [0, 20] 0.0178 0.0277 0.5217 1.02
[25, 30) -0.0011 0.0159 0.9436 1.000
[30,∞) -0.0513 0.0169 0.0024* 0.95
Hospitalization status ICU 0.1652 0.0500 0.001* 1.18
(v.s. not hospitalized) Not ICU -0.0279 0.0323 0.3868 0.97
Age per 5 years -0.0205 0.0030 <.0001* 0.98
Region (v.s. 5) 1 -0.1924 0.0453 <.0001* 0.83
2 0.0204 0.0213 0.3394 1.02
3 -0.0259 0.0276 0.3493 0.97
4 -0.0423 0.0222 0.0572 0.96
6 -0.0646 0.0479 0.1772 0.94
7 0.0611 0.0248 0.0135* 1.06
8 -0.0511 0.0304 0.0932 0.95
9 -0.0130 0.0232 0.5771 0.99
10 -0.0587 0.0285 0.0397* 0.94
11 -0.1753 0.0328 <.0001* 0.84
MELD per unit score -0.0078 0.0016 <.0001* 0.99
Albumin per mmol/L 0.0850 0.0107 <.0001* 1.09
Sodium per g/dL 0.0026 0.0018 0.1481 1.00
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CHAPTER 3
Joint Modeling of State Prevalence and Mortality
3.1 Introduction
In the data structure we consider, subjects (while alive) can switch back and forth between two
states, such that the subject is in one (and only one) of the two states until the terminating event
occurs. The term ‘prevalent’ will refer to the subject being in the state of interest. The follow-up
of each subject can be independently right censored.
In this chapter, we jointly model state prevalence (given survival) and death hazard by a shared
frailty term. In Chapters 1 and 2, the survival outcome was built into the definition of the state anal-
ogous to ‘prevalent’. The separation of the state prevalence and survival components in Chapter 3
implies that the residual correlation between the two processes must be taken into account.
The model of the prevalence outcome has a marginal interpretation, from the perspective that it
is conditional on survival, baseline covariates, external time-varying covariates, and frailty terms,
but not on the previous history. The linear predictor is connected to the probability of prevalence
outcomes through a known link function (for example, the logit function in this manuscript). This
model formulation is closely related to generalized linear mixed models (GLMMs) [McCulloch
and Neuhaus, 2001], but we also consider a shared frailty term in the death model. Instead of
constraining the same frailty term in both the prevalence and the death model, we incorporate an
unknown scale parameter to the death model, which distinguishes the frailty effect on the death
and prevalence process. Some previous methods have relaxed this assumption even further by
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estimating the correlation between the random effects of the two processes [Rizopoulos et al.,
2008].
Note that our proposed model accommodates a prevalent process indexed by a continuous time-
line. For example, in end-stage renal disease (ESRD) setting, a subject may stay in the hospital for
several days, and length of stay should not be ignored in the analysis. This unique data structure
prevents direct application of many joint modeling approaches for longitudinal and survival data
[Wulfsohn and Tsiatis, 1997, Tsiatis and Davidian, 2004, Yu et al., 2004, Chi and Ibrahim, 2006],
including several models for binary outcomes [Pulkstenis et al., 1998, Albert, 2000, Larsen, 2004].
Turning our attention now to another branch of methodology, many existing methods considered
a point process, implicitly assuming that the events have no duration [Liu et al., 2004, Ye et al.,
2007]. The afore-mentioned methods consider a type of data structure where outcomes are ob-
served at discrete time points. Moreover, we intend to build regression methods on the probability
of binary response, in order to have a prevalence interpretation, in contrast to models for transi-
tion probabilities [Albert, 2000, Shirley et al., 2010], many of which are built on a Markov type
assumption.
The method we propose in this chapter could be viewed as an extension to temporal process
regression methods proposed by Fine et al. [2004]. Their paper modeled P [Y (t)|S(t) = 1], where
Y (t) is observed on a continuous timeline and S(t) = 1 could be survival. The extension we make
is simultaneously modeling the death hazard by incorporating a shared frailty term and an unknown
scale parameter. Considering S(t) as survival indicator is attractive, because in most cases where
death is a terminal event, it will prevent the future occurrence of outcome Y (t). Similar conditional
modeling technique is employed in many recurrent/terminal event literature [Huang and Wang,
2004, Liu et al., 2004, Ye et al., 2007, Zeng and Cai, 2010, Kalbfleisch et al., 2013]. The big
distinction is that, in our case, the ”event” has a duration associated with it.
In models with unknown frailty terms, the primary difficulty involves the evaluation of marginal
likelihood, in sense that random effect need to be integrated out. In general, there are three options
in current literature. The first one is to obtain a tractable integration of the likelihood function by
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using specific link-random-effect combinations, e.g., complementary log-log link models with con-
jugate gamma random effects [Pulkstenis et al., 1998, Rondeau et al., 2007, Ye et al., 2007]. An-
other option is using numerical approaches to approximate the marginal likelihood function. Ex-
amples include marginal quasi-likelihood (MQL) [Goldstein, 1991] and penalized quasi-likelihood
(PQL) [Breslow and Clayton, 1993], which approximate generalized linear mixed models as linear
mixed models so that iterative generalized least squares (IGLS) [Goldstein, 1986] technique can
be applied. Gaussian quadrature can also be used to approximate the marginal likelihood by a sum
of integrand times suitably corresponding weights [Liu and Pierce, 1994, Li et al., 2017]. In the
presence of normal random effects, the marginal likelihood could also be approximated with a mix-
ture of binomial distributions [Thomas et al., 1998]. Finally some previous works here employed
Monte Carlo integration, for example importance sampling [Yu et al., 2004], and Metropolis sam-
pling [Liu et al., 2004, Chi and Ibrahim, 2006].
In this chapter, we consider an alternative approach to estimate covariate effects combining
both iterative updates and numerical approximation of the likelihood involving frailties. If frailties
and the scale parameter are known, then treating them as offsets, we could apply partial likelihood
[Cox, 1975] to estimate the regression coefficients, and apply generalized estimating equations
(GEEs) to estimate covariate effects for the prevalence model [Liang and Zeger, 1986]. On the
other hand, if those coefficients are known, we could estimate each frailty term from their cor-
responding estimating equation. The scale parameter and the variance of frailty terms could be
further estimated by numerical approximation approach (for example, Gaussian quadrature [Liu
and Pierce, 1994]). Following these ideas, we propose to iteratively update the frailty terms and
regression coefficients until convergence. It can be shown that our algorithm is equivalent to the
EM algorithm [Dempster et al., 1977], and, therefore, will maximize the marginal likelihood func-
tion by treating the frailty terms as missing data. More details are demonstrated in the following
section. We also propose an efficient method to approximate the asymptotic variance of covariate
effects which combines a Metropolis-Hastings algorithm and permutation methods.
The remainder of the chapter is organized as follows. We set up notation and describe our
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proposed methods in the next section. Simulation studies are performed to evaluate our method in
finite samples in Section 3 under various scenarios. In Section 4, we apply the proposed methods
to national ESRD data. Finally, concluding remarks are given in Section 5.
3.2 Proposed Methods
Suppose that there are n subjects. Let Di be the death (i.e., terminal event) time, and let Ci be
the censoring time for subject i (i = 1, 2, ..., n). We let Zi(t) be a p-dimensional external covari-
ate vector for subject i at time t [Kalbfleisch and Prentice, 2002], and let Z1i(t) = [1,ZTi (t)]
T .
Follow-up time t ∈ [0, τ ] is considered, where τ is a pre-specified constant satisfying Pr(Ci ≥
τ) > 0 for i = 1, 2, ..., n. In practice, one could choose τ as the maximum of observation time Xi,
where Xi = Ci ∧Di, with a ∧ b = min(a, b).
Let Pi(t) be an indicator function representing ‘prevalent’ at time t; i.e., Pi(t) = 1 if patient i
is in the state of interest and 0 otherwise. For example, being hospitalized, or being active on the
kidney transplant waiting list. We assume that the expectation of Pi(t) givenZ1i(t), νi and subject
i is alive has the following form,





where νi is a random effect or frailty term to absorb the residual correlations between Pi(t) and Di
within subject i. We assume a proportional hazard model with frailty terms νi on Di,





where γ is an unknown scale parameter, and λD0 (t) is an unspecified baseline hazard function for
the death time.
The frailty term νi is assumed to follow an independent normal distribution with variance σ2ν .
For identifiability, we set the normal distribution mean zero. Following the general set up in gen-
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eralized linear models (GLMs), g(·) is a link function between the expectation of the outcome and
the linear component. In this manuscript, we consider a logit link function, g(µ) = log[µ/(1−µ)],
to guarantee that fitted values of the conditional expectation are bounded by 0 and 1. Other link
functions could also be considered; for example, the probit function. Models like (3.1) have been
referred to as partial marginal in recurrent event analysis [Ye et al., 2007] and other areas of sur-
vival analysis (e.g., [Gong and Schaubel, 2013, 2017]), since the expectation is conditioning on
less information than a intensity function [Andersen and Gill, 1982], but more information than a
marginal mean model [Lin et al., 2000]. A practical convention is that the terminal event preclude
subsequent prevalence, such that Pi(t) = 0 for t ∈ [Di, τ ].
If the frailty term νi and the scale parameter γ were known, then we could apply partial like-
lihood [Cox, 1975] for model (3.2) in order to estimate α0, and generalized estimating equations
(GEE; Liang and Zeger [1986]) to estimate β0. Challenges include νi not being known, and the
lack of an explicitly specified error distribution.
3.2.1 Iterative Estimating Procedures
Before illustrating our estimating procedures, we first set up the requisite notation. Define the at-
risk indicator Yi(t) = I(Xi ≥ t), and an observed-death indicator ∆i = I(Di ≤ Ci). Observed
data for subject i are denoted by Oi = {Pi(t), Xi,∆i,Zi(t), t ∈ [0, Xi]}.
We make the following assumptions for the joint model:
1. Observed O1, ..., On are independent and identically distributed.
2. Two conditional independence assumptions for censoring:
(a) λDi [t|Zi(t), νi] = λDi [t|Zi(t), νi, Ci ≥ t]
(b) E[Pi(t)|Di ≥ t,Zi(t), νi] = E[Pi(t)|Xi ≥ t,Zi(t), νi]
Under models (3.1) and (3.2), and modeling assumptions (1) and (2) above, the likelihood
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This likelihood function can be considered as hierarchical or h-likelihood [Lee and Nelder, 1996,
Ha et al., 2001], and the log likelihood is therefore given by
l[α,β,ΛD0 , σ
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where the expit function is defined by expit(µ) = exp(µ)/[1 + exp(µ)]. We further denote
U 1(ν) = [U11(ν1), U12(ν2), ..., U1n(νn)]
T and ν = (ν1, ν2, ..., νn)T which are both n × 1 vectors.
Given α, β, dΛ0(t), t ∈ [0, Xi], σ2ν and γ, we could solve U 1(ν) through a Newton-Raphson
procedure to estimate ν, with starting values set to the estimates obtained based on using only the
prevalence data; this would amount to a GLMM [McCulloch and Neuhaus, 2001].
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Now consider a hypothetical scenario where ν and γ are known. In order to estimate α0
from model (3.2), we could apply partial likelihood [Cox, 1975]. Specifically, we could solve the








S(1)(α, t; ν, γ)
S(0)(α, t; ν, γ)
}
dNDi (t), (3.6)
where NDi (t) = I(Di ≤ Ci ∧ t), dNDi (t) = NDi (t− + dt)−NDi (t−),
S(k)(α, t; ν, γ) = n−1
∑n
i=1Zi(t)
⊗kYi(t)exp[αTZi(t) + γνi] for k = 0, 1, 2, where a⊗0 = 1,
a⊗1 = a, and a⊗2 = aaT . Let tD1, tD2, ..., tDm be them distinct ordered failure times. We need to










A Breslow method [Breslow, 1972] analog would be used to estimate dΛD0 by solving the follow-














Next we consider the estimation ofβ0 under the hypothetical scenario when ν and γ are known.
Having established l[α,β,ΛD0 , σ
2
ν , γ;Oi, νi] in (3.4), we could differentiate the sum of log likeli-













which is analog to the GEE version of logistic regression [McCulloch and Neuhaus, 2001], under
a working independence correlation structure.
Finally, we estimate σ2ν and γ using MLE techniques. Specifically, Gauss-Hermite quadrature
[Liu and Pierce, 1994] is used to approximate the integral of likelihood function (3.3) with respect
to ν. We denote the score function as U 5(σ2ν , γ). The basic idea of Gaussian quadrature is to
approximate an integral by a group of standard normal distributions with quadrature weight and
location of Gauss-Hermite quadrature. One could estimate σ2ν from only data pertinent to model
(3.1) to allow usage of standard software; for example, the package lme4 [Bates et al., 2015] in R.
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However, this would lose some efficiency and accuracy in the estimation.
In order to estimate all unknown parameters η = (νT ,αT , dΛDT0 ,β
T , σ2ν , γ)
T , we need to













T = 0. However the dimension of
U is (n + 2p + m + 3) × 1, which increases as sample size n increases. Therefore, generalized
estimating equations (GEEs) [Liang and Zeger, 1986] could not be directly applied. We propose
an iterative estimating approach to recursively update each parameter in η by treating the other
parameters known. The proposed procedure is summarized as follows;
1. Set initial values of dΛD(0)0 , α
(0), β(0), ν(0), σ2ν
(0) and γ(0). One could first fit GLMM to the
prevalence process to set σ2ν
(0) and ν(0), and let γ(0) = 1. Then get α(0), dΛD(0)0 and β
(0) as
the solutions to U 2(α), U 3(dΛD0 ), and U 4(β) with ν
(0), σ2ν
(0) and γ(0).
2. Replace [αT , dΛDT0 , σ
2
ν , γ]




, γ(0)]T in U 1(ν) to get updated esti-
mate ν(1).





4. Get estimates σ2ν
(1), γ(1) by solving U 5(σ2ν , γ) = 0.
5. Replace dΛD(0)0 , α
(0), β(0), ν(0), σ2ν
(0) and γ(0) by dΛD(1)0 , α
(1), β(1), ν(1), σ2ν
(1) and γ(1),




(1) in the last iteration as dΛ̂
D
0 and ν̂.
3.2.2 Robust Variance Estimators
If ν is known, then α̂ and β̂ are
√
n consistent estimators and the asymptotic variances could
be estimated through a robust (sandwich) estimator [Lin et al., 2000, Liang and Zeger, 1986].
However, substituting ν̂ in the sandwich estimators would severely underestimate the true variance,
since it does not account for the randomness in ν̂. Another challenge, as mentioned in the previous
section, is that the dimension of U increases as sample size increases. A bootstrap method [Efron
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and Tibshirani, 1994] could be applied, but requires intensive computation. Here we propose a
more efficient method to approximate the asymptotic variance of α̂ and β̂.
For each frailty νi, the first step is to use the Metropolis-Hastings algorithm to generate re-
alizations from f [νi|Oi], which is proportional to f [Oi|νi]f(νi) as defined in (3.3). Similar idea
is also used to approximate the information matrix with random effects [Liu et al., 2004]. The
remaining parameters α, β, dΛD0 , σ
2





γ̂ respectively. A total of 2000 samples are generated and the first 1000 samples serving only as
a burn-in period. We then calculate the empirical standard error from the 1000 samples after the
burn-in, and denote by σ̂2(ν̂i). The second step is to approximate the limiting distribution by per-
mutation methods[Lin et al., 1994]. To be specific, we generate 100 permutation samples. Within
jth permutation sample, we sample Gji from a standard normal distribution with mean zero and
variance one. Then replace νi by G
j
i × σ̂(ν̂i) in the estimating equations (3.6) and (3.8), and esti-
mate the asymptotic variance of α̂ and β̂ by their corresponding sandwich estimators. Finally, the
pooled variance estimators between 100 permutation samples are reported. In the next section, we
evaluate our robust variance estimator through simulations studies.
3.3 Simulation Studies
For each simulation setting, n = 500 subjects are generated. Covariates Z1 and Z2 follow
Bernoulli(0.5) distributions. Let Z = (Z1, Z2)T and Z1 = (1, Z1, Z2)T . We first generate ran-
dom effects ν from a mean-zero normal distribution with variance σ2ν , where σ
2
ν = 0.3 or 0.5.
The terminal event D is generated by transforming ε1 ∼ Uniform (0, 1) using hazard function
λD(t) = λD0 exp[α
T
0Z + γν], where α0 = (0.693,−0.693)T . In the first censoring setup, the
censoring time C is generated from an uniform distribution with minimum 90 and maximum 100,
and λD0 = 0.01. This would result in approximately 31% subjects being censored. In the second
censoring scenario, C is generated from a Uniform distribution with minimum 100 and maximum
150, and λD0 = 0.015, which lead to approximately 20% subjects being censored.
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The prevalence outcome P (t) is sampled from E[P (t) = 1|Z1, ν,X > t] = expit(βT0Z1 + ν),
where t is discrete, i.e., t = 1, 2, ..., T , where T = 100 in the first censoring scenario and T = 150
in the second one. Two magnitudes of β0 (including intercept) are considered: (1, 0.6,−0.6)T and
(1, 1,−1)T . The variance of the linear predictor ZT1 β0 would be 0.18 and 0.5 correspondingly.
Three levels of γ are considered: −0.5, 0, and 0.5.
Gauss-Hermite quadrature with 15 nodes is used to approximate the integral of likelihood func-
tion. Simulation results for β̂ and α̂ with 1000 replicates are summarized in Table 3.1 and 3.2. In
all simulation scenarios, the bias is relatively small, and asymptotic standard errors (ASEs) are
generally close to the corresponding empirical standard derivations (ESDs). The empirical cov-
erage probabilities (CPs) are quite close to the nominal 0.95. In Table 3.3 we present results for
σ̂2ν and γ̂. When γ is nonzero, the ASEs of γ̂ appear to slightly underestimate the corresponding
ESDs.
3.4 Real Data Analysis
We applied the proposed methods to data from the Dialysis Outcomes and Practice Patterns Study
(DOPPS) Phase 5. The DOPPS is a prospective, observational study designed to elucidate as-
pects of hemodialysis practice that are associated with the best outcomes for hemodialysis patients
[Young et al., 2000]. In particular, Phase 5 data were collected between 2012 and 2015. Our
research interests include identifying demographic and clinical variables that are associated with
out-of-hospital process and death process, considering their inner correlations.
The study population for DOPPS generally consists of prevalent patients. In the interests of
having t reflect time-since-dialysis-initiation instead of merely time-since-DOPPS-entry, we re-
stricted our study sample to include the n = 5, 298 patients who entered DOPPS within 3 months
of initiating dialysis. Patients included in our analysis were from 470 hemodialysis units across
11 different countries, with the counties including: Belgium, Canada, China, Gulf Coast Consor-




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3.3: Simulations Results for σ̂2ν and γ̂ based on n = 500 and 1000 Replicates
% C β σ2ν BIAS ASE ESD CP γ BIAS ASE ESD CP
≈ 30% (1, 0.6, -0.6) 0.3 -0.000 0.028 0.028 0.937 -0.5 -0.021 0.131 0.133 0.939
0.3 -0.001 0.027 0.027 0.939 0 -0.028 0.130 0.134 0.935
0.3 -0.002 0.028 0.027 0.951 0.5 -0.031 0.132 0.138 0.930
0.5 -0.002 0.043 0.042 0.948 -0.5 -0.016 0.097 0.104 0.932
0.5 -0.002 0.042 0.042 0.951 0 -0.016 0.095 0.100 0.939
0.5 -0.009 0.042 0.042 0.935 0.5 -0.024 0.099 0.100 0.930
(1, 1, -1) 0.3 -0.000 0.028 0.029 0.944 -0.5 -0.025 0.133 0.134 0.946
0.3 -0.002 0.028 0.028 0.938 0 -0.033 0.132 0.137 0.932
0.3 -0.002 0.028 0.027 0.953 0.5 -0.033 0.134 0.140 0.929
0.5 -0.003 0.043 0.043 0.949 -0.5 -0.020 0.098 0.104 0.929
0.5 -0.003 0.043 0.042 0.944 0 -0.018 0.096 0.102 0.935
0.5 -0.010 0.042 0.042 0.936 0.5 -0.025 0.100 0.100 0.939
≈ 20% (1, 0.6, -0.6) 0.3 0.001 0.029 0.029 0.950 -0.5 -0.013 0.112 0.123 0.911
0.3 -0.001 0.029 0.029 0.944 0 -0.024 0.110 0.112 0.938
0.3 -0.003 0.029 0.031 0.922 0.5 -0.032 0.114 0.117 0.934
0.5 -0.003 0.044 0.044 0.953 -0.5 -0.010 0.086 0.086 0.936
0.5 -0.006 0.044 0.043 0.944 0 -0.012 0.083 0.084 0.941
0.5 -0.012 0.044 0.043 0.940 0.5 -0.023 0.087 0.089 0.928
(1, 1, -1) 0.3 0.001 0.029 0.030 0.944 -0.5 -0.018 0.113 0.124 0.925
0.3 -0.001 0.029 0.029 0.951 0 -0.026 0.111 0.114 0.926
0.3 -0.004 0.029 0.031 0.925 0.5 -0.034 0.115 0.119 0.924
0.5 -0.004 0.045 0.044 0.944 -0.5 -0.012 0.086 0.087 0.938
0.5 -0.007 0.044 0.043 0.932 0 -0.014 0.083 0.084 0.940
0.5 -0.014 0.044 0.043 0.928 0.5 -0.026 0.087 0.089 0.921
age, race, gender, height, time on dialysis at study entry, as well as the following list of comorbid
conditions: coronary artery disease (CAD), cancer, cardiovascular disease (CVD), stroke, conges-
tive heart failure (CHF), diabetes, hypertension, chronic obstructive pulmonary disease (COPD),
psychiatric disorder and peripheral vascular disease (PVD).
Since hospitalization and death times are recorded in days, t represents day (i.e, day post
DOPPS entry) in our analysis. The mean number of hospital admissions was 0.595 per patient,
while the median length of stay per visit was 5 days. Observed follow-up time had a median of
326 days. Approximately 3% of subjects (154 subjects) were observed to die.
We fitted the model as described in Section 3.2.1 to the DOPPS data. Specifically, Gauss-
Hermite quadrature with 15 nodes is used to approximate the integral of likelihood function. Co-
variate effects for the out-of-hospital given alive (i.e. prevalence) process and the death hazard
are summarized in Table 3.4. For the prevalence process, coronary artery disease (p < 0.001),
cancer (p = 0.006), cardiovascular disease (p = 0.004), stroke (p = 0.045), chronic obstructive
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pulmonary disease (p = 0.004), psychiatric disorder (p = 0.011), and peripheral vascular disease
(p = 0.048) have significant negative effects on the probability of being out-of-hospital given sur-
vival. Patients from Belgium (p < 0.001), Canada (p < 0.001), China (p = 0.002), Gulf Coast
Consortium (p = 0.001), Germany (p < 0.001), Italy (p < 0.001), Japan (p < 0.001), Spain
(p = 0.002), Sweden (p < 0.001), and the United Kingdom (p < 0.001) have significantly lower
out-of-hospital probability than patients from the U.S. (reference). Time on dialysis (coded in
year) has a significantly negative effect (p = 0.003) on prevalence. For the mortality hazard, coro-
nary artery disease (p = 0.009) , cancer (p = 0.001), and chronic obstructive pulmonary disease
(p = 0.030) are associated with significantly higher death hazard. Patients from Italy (p = 0.042)
have a significant higher mortality rate than patents from the U.S. Increasing age (p = 0.003) is
also associated with a higher death hazard.
The frailty variance is estimated at σ̂2ν = 4.546 with standard error 0.158, indicating that there is
significant within-patient correlation given covariates. The estimated scale parameter γ̂ = −0.350
with standard error 0.037. This indicates that, given the covariates, the out-of-hospital process and
death hazard are negative correlated, which makes sense intuitively; i.e., patients that are more ill
(than accounted for their covariate pattern) could be less likely to be out-of-hospital while alive,
and more likely to die. Moreover, the frailty effects are stronger in the prevalence process than
that in the mortality process. We also compare the frailty estimates from the GLMM with logit
link using only the prevalence process. Figure 3.1 shows relatively high concordance between the
frailty estimates from the two models (Kendall’s tau correlation: 0.885, Pearson correlation: 0.977,
and Spearman’s rank correlation: 0.971). The majority of the absolute difference of frailty terms
between two models are below 0.7 (Figure 3.2).
3.5 Discussion
In this manuscript, we propose a method to jointly model the prevalence process and the mortality
hazard using a shared frailty model, allowing a scale parameter in the death process to be estimated.
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Figure 3.1: Scatterplots of Frailty Terms
Figure 3.2: Histogram of Absolute Difference of
Frailty Terms
The frailty terms are treated as fixed parameters in the iterative estimating procedures. We also
utilize a resampling method to obtain a robust variance estimator for the regression parameter
estimator.
In the application of the proposed methods to the DOPPS data, the scale parameter was esti-
mated at γ̂ = −0.350. This means that, given covariates, the out-of-hospital and mortality process
are negatively correlated, perhaps due to unmeasured confounders. Since |γ̂| < 1, then the preva-
lence process appears to have larger frailty variance than the mortality process. This finding is
consistent with the DOPPS data, since the contents of the covariate set for which data are obtained
are choosen primarily based on the perceived effects on mortality. From this perspective, it is
possible that some essential predictors for the prevalence model are not included in the analysis.
In Section 3.2.1, we described our iterative estimating procedures where frailty terms are up-
dated in each iteration. An alternative method would be to estimate frailty terms and variance σ2ν
using only the prevalence model, similar to a GLMM. Fixing each frailty term and random vari-
ance at their estimated values, the algorithm will converge faster. However, this alternative method
would lose some efficiency, because mortality information is abandoned. Moreover, it would likely
introduce more biases to the frailty estimates for subjects with small death time.
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The advantage of estimating frailty terms at each iteration is the allowance of using standard
softwares, for example R [R Development Core Team, 2008] and SAS [SAS Institute Inc., 2013].
Having ν̂ and γ̂, one could use the analog to logistic regression and Cox model to obtain β̂ and α̂
as described before. Similar to the estimation of γ and σν2, numerical approximation approached
could also be used to estimate β and α.
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Table 3.4: Analysis of DOPPS Data: Covariate Effects on the Out-of-Hospital given Alive Process and
Mortality Process
Prevalence model Mortality model
β̂ ŜE(β̂) p α̂ ŜE(α̂) p exp(α̂)
Intercept 7.510 0.204 <0.001* - - - -
Female -0.137 0.194 0.481 -0.193 0.223 0.388 0.825
CADa -0.886 0.184 <0.001* 0.561 0.213 0.009* 1.752
Cancer -0.618 0.224 0.006* 0.683 0.211 0.001* 1.980
CVDb -0.582 0.203 0.004* 0.419 0.227 0.065 1.520
Stroke -0.460 0.230 0.045* -0.035 0.284 0.901 0.965
CHFc -0.099 0.184 0.590 0.222 0.203 0.274 1.248
Diabetes -0.060 0.163 0.712 -0.284 0.178 0.109 0.752
Hypertension 0.243 0.207 0.241 -0.092 0.216 0.670 0.912
COPDd -0.654 0.225 0.004* 0.520 0.240 0.030* 1.682
Psychiatric Disorder -0.568 0.225 0.011* 0.460 0.264 0.082 1.584
PVDe -0.362 0.183 0.048* 0.164 0.215 0.445 1.178
Belgium -1.968 0.323 <0.001* -0.279 0.525 0.596 0.757
Canada -1.406 0.312 <0.001* -0.216 0.386 0.576 0.806
China -1.325 0.434 0.002* -0.401 1.017 0.693 0.670
Gulf -1.215 0.365 0.001* -0.025 0.531 0.963 0.976
Germany -2.179 0.245 <0.001* -0.051 0.324 0.874 0.950
Italy -1.195 0.288 <0.001* 0.582 0.287 0.042* 1.789
Japan -1.455 0.286 <0.001* -0.647 0.366 0.077 0.524
Spain -1.044 0.334 0.002* 0.028 0.374 0.941 1.028
Sweden -2.094 0.331 <0.001* 0.082 0.527 0.876 1.086
UK -1.378 0.380 <0.001* -0.179 0.520 0.730 0.836
Age (per 5 years) 0.018 0.028 0.537 0.103 0.034 0.003* 1.108
Time on dialysis (years) -3.092 1.050 0.003* 0.709 1.093 0.517 2.031
Height (per 10 cm) 0.064 0.103 0.536 -0.116 0.112 0.299 0.890
a: Coronary artery disease
b: Cardiovascular disease
c: Congestive heart failure
d: Chronic obstructive pulmonary disease
e: Peripheral vascular disease
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APPENDIX A
Supplemental Materials to Chapter 1
A.1 Notations and Assumptions
We first list the notations and assumptions that are presented in the main paper.
A0i (t) = I{Hi(t) = 0, Di > t}: Survival-out-of-hospital indicator for subject i at time t.
πi(t) ≡ E[A0i (t)|Zi(t)]: Survival-out-of-hospital probability for subject i at time t.
dM∗i (t;β) = A
0
i (t)dt − π0(t)exp[βTZi(t)]dt: Survival-out-of-hospital Martingale increment for
subject i at time t.
dMi(t;β) = dM
∗
i (t;β)I(Ci ≥ t): Observed survival-out-of-hospital Martingale increment for
subject i at time t.
NCi (t) = I(Ci ≤ t ∧Di): Observed censoring time counting process for subject i at time t.
dNCi (t) = N
C
i (t
− + dt) − NCi (t−): Censoring time counting process increment for subject i at
time t.
Xi = Di ∧ Ci: Observed terminal event for subject i.
Yi(t) = I(Xi ≥ t): At-risk process for censoring time for subject i at time t.
I(C
〈m〉
i ≥ t; θ̂): At-risk process when C
〈m〉
i is imputed from Ĝ(t; θ̂) for subject i at time t.
I(C
〈m〉
i ≥ t;θ0): At-risk process when C
〈m〉
i is imputed from G(t;θ0) for subject i at time t.
dM
〈m〉




i ≥ t;θ): Observed survival-out-of-hospital Martingale incre-
ment for imputation m for subject i at time t.
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Let S(k)(t;β) = n−1
∑n
i=1Zi(t)
⊗kI(Ci ≥ t)exp{βTZi(t)}, and
s(k)(t;β) = E[Z1(t)
⊗kI(C1 ≥ t)exp{βTZ1(t)}] be the limiting value of S(k)(t;β) for k =
0, 1, 2, where a⊗0 = 1, a⊗1 = a, and a⊗2 = aaT . Also let Z̄(t;β) = S(1)(t;β)/S(0)(t;β), and










{s(2)(t;β)/s(0)(t;β)− z̄(t;β)⊗2}A01(t)I(C1 ≥ t)dt].







and s(k)〈1〉(t;β,θ) = E[Z1(t)⊗kI(C
〈1〉
1 ≥ t;θ)exp{βTZ1(t)}] be the limiting value ofS(k)〈m〉(t;β,θ)
for k = 0, 1, 2. Also let Z̄〈m〉(t;β,θ) = S(1)〈m〉(t;β,θ)/S(0)〈m〉(t;β,θ), and denote its limiting








{S(2)〈m〉(t;β,θ)/S(0)〈m〉(t;β,θ) − Z̄〈m〉(t;β,θ)⊗2}A0i (t)I(C
〈m〉
i ≥







Proportional marginal rate model on the hospital-free survival event:
πi(t) = π0(t)exp{βT0Zi(t)} (A.1)
Conditional independent censoring assumption:
E{A0i (t)|Zi(t), I(Ci ≥ t)} = E{A0i (t)|Zi(t)} (A.2)
Proportional hazard model on the censoring time:




A.2 Proof of Theorem 1
A.2.1 Consistency of β̂






[(β − β0)TZi(t)− log
S(0)(β, t)
S(0)(β0, t)








Note that ∂Xn(β)/∂β = Un(β).
For an arbitrary δ > 0, consider a compact set Bδ = {β : ‖β − β0‖ ≤ δ}. Evaluated at
β = β0, ∂X(β)/∂β = E[
∫ τ
0
{Z1(t) − z̄(t;β0)}A01(t)I(C1 ≥ t)dt] = 0 by model assumptions,
while −∂2X(β)/∂β∂βT = Ω(β0), which is positive definite by condition (c). Therefore, X(β)
is concave and has a local maximum at β = β0. We have X(β0) ≥ X(β) for β ∈ Bδ, and
X(β0) > X(β) for β ∈ ∂Bδ, where ∂Bδ = {β : ‖β − β0‖ = δ}. For β ∈ Bδ, by SLLN,
n−1Xn(β)
a.s.→ X(β). By continuous mapping theorem,
‖n−1Xn(β)− n−1Xn(β0)‖
a.s.→ ‖X(β)−X(β0)‖
where ‖a‖ = (aTa)1/2. Therefore as n → ∞, Xn(β0) ≥ Xn(β) for β ∈ Bδ, and Xn(β0) >
Xn(β) for β ∈ ∂Bδ. In this case, when n → ∞, Xn(β) has a maximum β0 in Bδ. Moreover,
evaluated at β̂, ∂Xn(β)/∂β = U(β) = 0, meaning that β̂ is the local maximum. Taking δ
arbitrary small, we would have β̂ a.s.→ β0.
A.2.2 n1/2(β̂ − β0)
To show the asymptotic distribution of n1/2(β̂ − β0), we take the first-order Taylor expansion of
Un(β0) around β̂ to get n−1/2Un(β0) = n1/2Ω̂(β
∗)(β̂ − β0), where β∗ is on the line segments
between β0 and β̂. The consistency of β̂ and Ω̂(β0) for β0 and Ω(β0), along with the positive
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definite of Ω(β0) imply that
n1/2(β̂ − β0) = n−1/2Ω(β0)−1Un(β0) + op(1) (A.4)






{Zi(t)− Z̄(t;β0)}dMi(t;β0) = 0 (A.5)
where dMi(t;β) = A0i (t)I(Ci ≥ t)dt− I(Ci ≥ t)exp[βT (t)Zi(t)]π0(t)dt. Without lose of gener-
ality, we assume that Zi(t) ≥ 0. Therefore, S(1)(t;β0) and S(0)(t;β0) are monotone functions in
t and converges almost surely to s(1)(t;β0) and s(0)(t;β0) by SLLN. Then applying Lemma 1 of






{Z̄(t;β0)− z̄(t;β0)}dMi(t;β0) = op(1) (A.6)
Combining (A.4), (A.5) and (A.6), we could represent n1/2(β̂ − β0) as a sum of independent
and identically distributed random variables,
n1/2(β̂ − β0) = n−1/2
n∑
i=1
fβi (β0) + op(1) (A.7)
where fβi (β) = Ω(β)
−1ui(β) and ui(β) =
∫ τ
0
{Zi(t) − z̄(t;β)}dMi(t;β). Since S(k)(t;β0)
(k = 0, 1, 2) and Zi(t) are totally bounded by condition (c), then Theorem 1 follows by Multi-
variate Central Limit Theorems. The consistency of Σ̂(β̂) could be proved by iteratively applying
SLLN, Lemma 1 of Lin et al (2000) and the strong consistency of β̂.
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A.3 Proof of Theorem 2






i (t)I(Ci ≥ t)
n−1/2
∑n






We introduce some empirical process notations for the ease for derivations. Let Pnf = n−1
∑n
i=1 fi(Fi)
and Pf = E[f1(F1)]. The empirical process {Gnf(t) : t ∈ [0, τ ]}, where Gnf(t) = n1/2[Pnf(t)−
Pf(t)], can be identified as the empirical distribution of observations indexed by the function
fi(t, Fi), for t ∈ [0, τ ]. In the following proof, we will drop the notation of data Fi in the parenthe-






[A0i (t)I(Ci ≥ t)]− E[A01(t)I(C1 ≥ t)]
)
= Gnf̃π1(t)
where f̃π1i (t) = A
0







Zi(t)]} − E{I(C1 ≥ t)exp[βT0Z1(t)]}
)
in the denominator,


































I(Ci ≥ t)exp[βT0Zi(t)]ZTi (t)n−1
n∑
l=1










Tfβi (β0) + op(1) (A.10)
where (A.10) is by the strong consistency and monotonic property of S(1)(t;β0). Combining








Zi(t)]} − E{I(C1 ≥ t)exp[βT0Z1(t)]}
)
= Gnf̃π2(t;β0) + op(1)
(A.11)
where f̃π2i (t;β) = s
(1)(t;β0)
Tfβi (β0) + I(Ci ≥ t)exp[β
T
0Zi(t)].
By the empirical central limit theorem (van der Vaart and Wellner (1996), example 3.9.19, p.g.
383), we have:
n1/2






where Gf̃π1 and Gf̃π2 are tight Gaussian processes. Define a map
(A,B) 7→ A
B
Since this composition map is Hadamard-differentiable, 1/B is bounded away from zero and
A is of bounded variation, then its derivative map is given by





By Functional Delta method (van der Vaart (1998), p.g. 291)

















Therefore Theorem 2 follows, and by the consistency of β̂ and Pnf to β0 and Pf , respectively,
we have σ̂(s, t) converges in probability to σ(s, t).
A.4 Proof of Theorem 3
A.4.1 Consistency of β̂
M
Before establishing the consistent property, we first show some useful results. When C〈m〉i is
imputed with the true underlying G(t;θ0), I(C
〈m〉
i ≥ t;θ0) and A0i (t) are independent condition
on Zi(t) by (A.2):
E[A0i (t)I(C
〈m〉
i ≥ t;θ0)|Zi(t)] = E[A0i (t)|Zi(t)]E[I(C
〈m〉
i ≥ t;θ0)|Zi(t)] = 0
E[{A0i (t)I(C
〈m〉
i ≥ t;θ0)}2|Zi(t)] = E[{A0i (t)}2|Zi(t)]E[{I(C
〈m〉
i ≥ t;θ0)}|Zi(t)]
Next consider I(C〈m〉i ≥ t; θ̂), where C
〈m〉
i are imputed from Ĝ(t; θ̂) if N
D
i (Xi) = 1. The
survival function of imputed censoring time given Zi(t) and NDi (Xi) = 1 is given by
E[I(C
〈m〉
i ≥ t; θ̂|Zi(t), NDi (Xi) = 1] = I(t ≥ Di)exp{[Λ̂Ci (Di; θ̂)− Λ̂Ci (t; θ̂)]
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Using the strong consistency of θ̂ and SLLN, we have dΛ̂C0 (t; θ̂) − dΛC0 (t) converges almost
surely to zero. Applying continuous mapping theorem, we have
E[I(C
〈m〉
i ≥ t; θ̂)|Zi(t), NDi (Xi) = 1]
a.s.→ E[I(C〈m〉i ≥ t;θ0)|Zi(t), NDi (Xi) = 1] (A.13)
which means that asymptotically,C〈m〉i are drawn from the trueG(t;θ0) for subjects withN
D
i (Xi) =
1. Note that for subjects NDi (Xi) = 0, I(C
〈m〉
i ≥ t;θ0) = I(C
〈m〉
i ≥ t; θ̂) = I(Ci ≥ t), then com-
bining (A.13) we have
E[I(C
〈m〉
i ≥ t; θ̂)|Zi(t)] = E[I(C
〈m〉
i ≥ t;θ0)|Zi(t)] + o(1) (A.14)




i ≥ t; θ̂)|Zi(t)] = E[A0i (t)|Zi(t)]E[I(C
〈m〉
i ≥ t; θ̂)|Zi(t)] + o(1) = o(1) (A.15)
E[{A0i (t)I(C
〈m〉
i ≥ t; θ̂)}2|Zi(t)] = E[{A0i (t)}2|Zi(t)]E[{I(C
〈m〉
i ≥ t; θ̂)|Zi(t)] + o(1) (A.16)















i ≥ t;θ0) converge to the same limiting process. By Donsker’s







i ≥ t;θ0) converges to a Gaussian







i ≥ t; θ̂)
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i ≥ t;θ0) + op(1)
(A.17)
Now we are ready to show the consistency. Within the mth imputed dataset, define




















Note that A0i (t)I(C
〈m〉
i ≥ t;θ0) = A0i (t)I(C
〈m〉
i ≥ t; θ̂), because A0i (t) = 0 for t ∈ [Di, τ ]. We
have S(k)〈m〉(t;β, θ̂) converges almost surely to s(k)〈1〉(t;β,θ0) by SLLN, (A.14) and (A.15), for








Following the arguments in the proof of theorem 1, we have ‖β̂
〈m〉
−β0‖





− β0‖, then by triangle inequality, ‖β̃
M − β0‖









Having established the strong consistency of β̂
〈m〉
, we could apply first-order Taylor expansion on
U
〈m〉

















Iteratively applying WLLN, and by (A.2) (A.14) we have Ω̂
〈m〉
(β0, θ̂)




















































Since Zi(t) has bounded total variations, then by (A.17), we could show that (A.19) equals
to op(1). Without lose of generality we assume that Zi(t) ≥ 0. Therefore, S(1)〈m〉(t;β0, θ̂) and
S(0)〈m〉(t;β0, θ̂) are monotone functions in t. By Lemma 1 in LWYY 2000, (A.17), the strong









i (β0,θ0) + op(1)
where u〈m〉i (β,θ) =
∫ τ
0


















i (β0,θ0) + op(1)
By multivariate central limit theorem, n1/2(β̂
M
− β0) converges to a mean zero normal random
























proved in similar manners of Theorem 1.
A.5 Proof of Theorem 4















































































































By (A.14), the first term (A.23) can be shown to be op(1). By (A.22), the strong consistency of


















i ≥ t; θ̂)exp[Z(t)T β̃
M
]} − E{I(C〈1〉1 ≥ t;θ0)exp[βT0Z(t)]}
)
=Gnf̃π2(t;β0,θ0,M) + op(1) (A.26)






Following similar arguments in the Proof of Theorem 2, we have Theorem 4.
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APPENDIX B
Supplemental Materials to Chapter 2
B.1 Notations
Zi(t): External covariates for subject i at time t.
X i(t): The history of internal covariates for subject i up to time t.
Ei(t): Indicator of the state of interest for subject i at time t.
Ai(t) = I{Ei(t) = 1}I(Di > t): Indicator of being alive and staying in the state of interest for
subject i at time t.
C1i: Conditional independent censoring time for subject i.
C2i: Dependent censoring time for subject i.
Ci = C1i ∧ C2i: Observed censoring time for subject i at time t.
dM∗i (t;β) = Ai(t)dt − π0(t)exp{βTZi(t)}dt: Martingale increment of the target of interest for
subject i at time t.
dMi(t;β) = Ai(t)I(Ci ≥ t)dt−π0(t)exp{βTZi(t)}I(Ci ≥ t)dt: Observed Martingale increment
of the target of interest for subject i at time t.
Xi = Ci ∧Di: Observed terminal event time for subject i at time t.
NC2i (t) = I(C2i ≤ t ∧ Xi): Observed counting process of dependent censoring for subject i at
time t.
dNC2i (t) = N
C2
i (t
− + dt)−NC2i (t−): Counting process increment of observed dependent censor-
ing for subject i at time t.
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Yi(t) = I(Xi ≥ t): At-risk process for dependent censoring for subject i at time t.






0X i(t)]Yi(t)dt: Martingale increment of observed dependent
censoring for subject i at time t.
WAi (t;θ) = I(C2i ≥ t)exp{
∫ t
0
[λC20 (s) + θ
T
0X i(s)]Yi(s)ds}: Type A weights for subject i at time
t.
WBi (t;θ) = I(C2i ≥ t)exp{
∫ t
0
θT0X i(s)Yi(s)ds}: Type B weights for subject i at time t.
Let X(k)(t) = n−1
∑n
i=1X i(t)
⊗kYi(t), and x(k)(t) = E[X1(t)⊗kY1(t)] be the limiting value
of X(k)(t) for k = 0, 1, 2, where a⊗0 = 1, a⊗1 = a, and a⊗2 = aaT . Denote X̄(t) =

















and z(k)(t;β,W ) = E[Z1(t)⊗kI(C11 ≥ t)W1(t)exp{βTZ1(t)}] be the limiting value ofZ(k)(t;β,W )
for k = 0, 1, 2. Denote Z̄(t;β,W ) = Z(1)(t;β,W )/Z(0)(t;β,W ), and its limiting value as
z̄(t;β,W ) = z(1)(t;β,W )/z(0)(t;β,W ). Moreover, define





{Z(2)(t;β,W )/Z(0)(t;β,W )−Z̄(t;β,W )⊗2}Ai(t)I(C1i ≥ t)dt and its
limiting value Ω(β,W ) = E[
∫ τ
0
{z(2)(t;β,W )/z(0)(t;β,W )−z̄(t;β,W )⊗2}A1(t)I(C11 ≥ t)dt].
B.2 Assumptions
Let
λC2i {t} = lim
δ→0
δ−1Pr[t ≤ C2i < t+ δ|Di ≥ t, C2i ≥ t, X̃ i(t)]
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No unmeasured confounders assumption:
λC2i {t|X̃ i(t)} = λ
C2
i {t|X̃ i(t), C1i, C1i ≥ t,Di, Di ≥ t, Ei(s), s ∈ (t, τ ]} (B.1)
Note that X̃ i(t) includes Zi(t).
Assumptions for independent censoring time C1:
E[Ai(t)|Zi(t), C1i ≥ t, C1i] = E[Ai(t)|Zi(t)] (B.2)
Additive hazard model on dependent censoring C2i:
λC2i (t) = λ
C2
0 (t) + θ
TX i(t) (B.3)
Model assumptions on the target of interest:
πi(t) = π0(t)exp[βT0Zi(t)]
or









[Ai(t)− πi(t)]I(C1i ≥ t)Wi(t)dt = 0 (B.6)
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B.3 Regularity Conditions for C1i and C2i
1. {Xi, Yi(t),X i(t),Zi(t), I(C1i ≤ Di∧C2i), I(C2i ≤ Di∧C1i)} for t ∈ [0, Xi], i = 1, 2, ..., n
are independent and identically distributed.
2. Pr(Ci ≥ τ) > 0 for i = 1, 2, ..., n, where τ is a pre-specified constant.
3. NC1i (τ) < η1 <∞ and N
C2




|dZij(t)| < cZ < ∞ and |X ij(0)| +
∫ τ
0
|dX ij(t)| < cX < ∞ almost surely
for i = 1, 2, ..., n, j = 1, 2, ..., p, i.e., Zi(t) andX i(t) have bounded total variations.
5. Let z(k)C1 (t;γ) = E[Z1(t)













(t;γ0)−z̄C1(t;γ0)⊗2}Y1(t)dNC11 (t)] and ΩC2 are positive
definite.
6. For γ ∈ Bδ1 where Bδ1 is a small neighborhood around γ0, z
(0)
C1
(t;γ), z(1)C1 (t;γ), x
(0)(t) and
x(1)(t) are bounded away from zero.
B.4 Proof for Known Censoring Time
B.4.1 n1/2(θ̂ − θ)
By no unmeasured confounders assumption (B.1), C1i ∧ Di is independent of C2i conditional on






{X i(t)− X̄(t)}dMC2i (t;θ)
and the expectation ofUC2(θ0) would be zero (Lin and Ying 1994, Schaubel et al. 2006). Let θ̂ be
the solution of UC2(θ) = 0, then θ̂ is a strong consistent estimator for θ. Furthermore, by Taylor
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expansion and the consistency of θ̂ we have







{X i(t)− X̄(t)}dMC2i (t;θ0) + op(1) (B.7)
Without lose of generality, we assume that X i(t) ≥ 0, then X(1)(t) and X(0)(t) are monotone
function in t and converge almost surely to x(1)(t) and x(0)(t) by SLLN. Iteratively applying





{X i(t) − X̄(t)}dMC2i (t;θ0) as






{X i(t)− X̄(t)}dMC2i (t;θ0) = n−1/2
n∑
i=1





{X i(t)− x̄(t)}dMC2i (t;θ)
By the consistency of θ̂ and Ω̂
C2
, we could re-write (B.7) as
n1/2(θ̂ − θ0) = [ΩC2 ]−1n−1/2
n∑
i=1
uC2i (θ0) + op(1) (B.8)
Then by multivariate central limit theorem, we have n1/2(θ̂ − θ0) converges in distribution to a
mean zero normal random variable.
B.4.2 n1/2{dΛ̂C20 (t; θ̂)− dΛ
C2
0 (t)}
By Lin and Ying 1994, the estimator of baseline hazard increment dΛ̂C20 (t) is given by









Consider n1/2[dΛ̂C20 (t; θ̂)− dΛC20 (t)], which can be decomposed as










By WLLN and continuous mapping theorem, we have ĥC2(t) converges in probability to hC2(t).
Then the first term in (B.9) could be written as














uC2i (θ0) + op(1) (B.10)
Next consider the second part:


















x(0)(t)−1dMC2i (t;θ0) + op(1) (B.11)
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where the last equality follows from Lemma 1 of Lin et al. 2000. Combining (B.10) and (B.11),
we have
n1/2[dΛ̂C20 (t; θ̂)− dΛC20 (t)] = n−1/2
n∑
i=1
fC0i (t,θ0) + op(1) (B.12)
where
fC0i (t,θ) = h
T
C2
(t)[ΩC2 ]−1uC2i (θ) + x
(0)(s)−1dMC2i (t;θ)
By Central Limit Theorem, we have n1/2[dΛ̂C20 (t; θ̂) − dΛC20 (t;θ0)] converges in distribution to a
mean zero normal random variable, with variance E[fC01 (t,θ0)
2].
B.4.3 n1/2{dΛ̂C2i (t; θ̂)Yi(t)− dΛ
C2
i (t;θ0)Yi(t)}
Similar to the previous section, we could decompose the target quantity as
n1/2{dΛ̂C2i (t; θ̂)Yi(t)− dΛ
C2
i (t;θ0)Yi(t)} =n1/2(θ̂ − θ0)TX i(t)Yi(t)dt+ (B.13)
n1/2[dΛ̂C20 (t; θ̂)− dΛC20 (t)]Yi(t) (B.14)
By (B.8), the first term (B.13) could be written as
n1/2(θ̂ − θ0)TX i(t)Yi(t)dt = XTi (t)[ΩC2 ]−1Yi(t)n−1/2
n∑
l=1
uC2l (θ0)dt+ op(1) (B.15)
Combining (B.15) and (B.12), we have n1/2[dΛ̂C2i (t; θ̂)Yi(t)−dΛ
C2











(t)][ΩC2 ]−1uC2l (θ)Yi(t) + x
(0)(t)−1dMC2l (t;θ)Yi(t)
By Central Limit Theorem again, we have n1/2[dΛ̂C2i (t; θ̂)Yi(t) − dΛ
C2
i (t;θ0)Yi(t)] converges in
distribution to a mean zero normal random variable, with variance E[fCi1 (t,θ0)
2].
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B.4.4 n1/2{ŴAi (t; θ̂)−WAi (t;θ0)}











then by Taylor expansion and results of B.4.3 we have





fCil (s,θ0) + op(1) (B.16)
B.4.5 n1/2{ŴBi (t; θ̂)−WBi (t;θ0)}
The target quantity is given by














XTi (s)Yi(s)(θ̂ − θ0)ds+ op(1)
Combining results with (B.8) we have





fXil (s,θ0) + op(1) (B.17)




B.4.6 Consistency of β̂A
Consider the two estimating equations
n∑
i=1








i (t;θ)dMi(t;β) = 0 (B.19)











[1− dΛC21 (r)]−1I(C21 ≥ t)
Then consider the expectation of (B.18) condition onX1(t). The first scenario is when t ≤ D1:








−)E[dM∗1 (t;β0)I(C21 ≥ t)I(C11 ≥ t)|X1(t), t ≤ D1]
=E[dM∗1 (t;β0)I(C21 > t
−)I(C11 ≥ t)|C21 ≥ t−,X1(t), t ≤ D1][1− dΛC2i (t−)]−1∏
r∈(0,t−)
E[C21 > r|C21 ≥ r,X1(r)][1− dΛC2i (r)]−1
=E[dM∗1 (t;β0)I(C21 > t
−)I(C11 ≥ t)|C21 ≥ t−,X1(t), t ≤ D1][1− dΛC2i (t−)]−1
=E[dM∗1 (t;β0)I(C11 ≥ t)|C21 ≥ t−,X1(t), t ≤ D1]
E[I(C21 > t
−)|C21 ≥ t−,X1(t), t ≤ D1][1− dΛC2i (t−)]−1
(B.20)
=E[dM∗1 (t;β0)I(C11 ≥ t)|C21 ≥ t−,X1(t), t ≤ D1]
=E[dM∗1 (t;β0)I(C11 ≥ t)|X1(t), t ≤ D1] (B.21)
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where (B.20) and (B.21) are by no unmeasured confounders assumption (B.1). As for t > D1, we
have dM∗1 (t;β0) is only a function of Z1(t) because A1(t) = 0. In this case
E{WA1 (t−;θ0)dM1(t;β0)|X1(t), t > D1}
=E{eΛ
C2
1 (D1)dM∗1 (t;β0)I(C21 ≥ t)I(C11 ≥ t)|X1(t), t > D1}
=eΛ
C2
1 (D1)E[dM∗1 (t;β0)I(C21 ≥ t)I(C11 ≥ t)|X1(t), t > D1]
=E[dM∗1 (t;β0)I(C21 > D1)I(C11 ≥ t)|C21 ≥ D1,X1(t), t > D1]∏
r∈(0,D1]
E[C21 > r|C21 ≥ r,X1(r)][1− dΛC2i (r)]−1
=E[dM∗1 (t;β0)I(C11 ≥ t)|C21 ≥ t−,X1(t), t > D1] (B.22)
=E[dM∗1 (t;β0)I(C11 ≥ t)|X1(t), t > D1]
where (B.22) is by the fact that given t > D1 (death is observed), C21 is infinity and therefore
C21 > D1. Combining the two scenarios, we have
E{WA1 (t−;θ0)dM1(t;β0)|X1(t)} = E[dM∗1 (t;β0)I(C11 ≥ t)|X1(t)].
SinceX1(t) contains Z1(t), then iterating expectations we have
E{WA1 (t;θ0)dM1(t;β0)|Z1(t)}
=E[dM∗1 (t;β0)I(C11 ≥ t)|Z1(t)]
=E[dM∗1 (t;β0)|Z1(t)]E[I(C11 ≥ t)|Z1(t)] (B.23)
=0 (B.24)
where (B.23) is by conditional independent censoring assumption (B.2) and (B.23) is by the as-
sumption (B.4). Similarly, we could show that (B.19) has expectation zero. Solving (B.18) and
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{Zi(t)− Z̄[t;β,WA(θ)]}WAi (t;θ)dMi(t;β) = 0
Consider the estimating equation with estimated weights ŴA(t; θ̂), i.e.,





{Zi(t)− Z̄[t;β, ŴA(θ̂)]}ŴAi (t; θ̂)dMi(t;β) = 0 (B.25)
By SLLN and the strong consistency of ŴAi (t;θ) toW
A
i (t;θ) and θ̂ to θ0, we have that n
−1U [β, ŴA(θ̂)]
converges almost surely to zero. Then by the positive definite of Ω[β0,WA(θ0)] and arguments in
Lin et al. 2000 A1, the solution of (B.25) β̂A is a consistent estimator of β0.
B.4.7 n1/2(β̂A − β)
Since β̂A is the solution of estimating equation





{Zi(t)− Z̄(t;β, ŴA)}ŴAi (t; θ̂)dMi(t;β) = 0
then by Taylor expansion and the consistency of Ω̂[β0, ŴA(θ̂)] to Ω[β0,WA(θ0)] we have
n1/2(β̂A − β0) = Ω[β0,WA(θ0)]−1n−1/2U [β0, ŴA(θ̂)] + op(1) (B.26)
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{Zi(t)− Z̄[t;β0,WA(θ0)]}[ŴAi (t; θ̂)−WAi (t;θ0)]dMi(t;β0) (B.29)






{Zi(t)− z̄[t;β0,WA(θ0)]}WAi (t;θ0)dMi(t;β0) + op(1). Specifically, since Zi(t)
and X i(t) are bounded, we assume without lose of generality that Zi(t) ≥ 0 and X i(t) ≥ 0.
Therefore, Z(0)[t;β0,WA(θ0)] andZ
(1)[t;β0,W
A(θ0)] are monotone functions in t and converges
almost surely to z(0)[t;β0,WA(θ0)] and z(1)[t;β0,WA(θ0)]. Iteratively applying Lemma 1 in Lin
et al. 2000, we establish the previous result. By Zhang and Schaubel 2011, the second term (B.28)
















































































where (B.31) is by iteratively applying SLLN. Combing (B.27) and (B.31) we have





i (θ0,β0) + op(1) (B.32)





H [β,θ,WA(θ)][ΩC2 ]−1uC2i (θ)+
∫ τ
0
J [t, τ,β,θ,WA(θ)]dMC2i (t;θ)
]
. Therefore, n1/2(β̂A−β0)







B.4.8 Consistency of β̂B
Similar to (B.24), we can show thatWB1 (t;θ0)dM1(t;β0) have expectation zero condition on exter-













dΛC20 (s;θ)]. Since D1 is observed, then exp[−
∫ D1
0
dΛC20 (s;θ)] is also a func-
tion of t. Therefore combing two scenarios and iterating the expectation on Zi(t), we also get two
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mean zero estimating equations
n∑
i=1







i (t;θ)dMi(t;β) = 0 (B.34)
Then the consistency of β̂B could be proved in similar manners as of β̂A.
B.4.9 n1/2(β̂B − β0)
We have β̂B is the solution of estimating equation





{Zi(t)− Z̄[t;β, ŴB(θ̂)]}ŴBi (t; θ̂)dMi(t;β) = 0
and by Taylor expansion and the strong consistency of Ω̂[β0, ŴB(θ̂)] to Ω[β0,WB(θ0)] we have
n1/2(β̂B − β0) = Ω[β0,WB(θ0)]−1n−1/2U [β0, ŴB(θ̂)] + op(1) (B.35)


























{Zi(t)− Z̄[t;β0,WB(θ0)]}[ŴBi (t; θ̂)−WBi (t;θ0)]dMi(t;β0) (B.38)
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{Zi(t) − z̄[t;β0,WB(θ0)]}WBi (t;θ0)dMi(t;β0) + op(1), the second term (B.37)

































Combing results we have





i (θ0,β0) + op(1) (B.40)








. Therefore, n1/2(β̂B − β0) converges in distribution to a




B.4.10 n1/2{π̂A0 (t)− π0(t)}




i=1[I(Ci ≥ t)Ai(t)ŴAi (t; θ̂)]− E[I(C1 ≥ t)A1(t)WA1 (t;θ0)]}








[I(Ci ≥ t)Ai(t)ŴAi (t; θ̂)]− n−1
n∑
i=1




[I(Ci ≥ t)Ai(t)WAi (t;θ0)]− E[I(C1 ≥ t)A1(t)WA1 (t;θ0)] (B.42)































































f̃π11,Ai (t) + op(1) (B.43)




[I(Ci ≥ t)Ai(t)ŴAi (t; θ̂)]− E[I(C1 ≥ t)A1(t)WA1 (t;θ0)]} = Gnf̃π1,A + op(1)
(B.44)
where f̃π1,Ai (t) = f̃






Zi(t)ŴAi (t; θ̂)]− E[I(C1 ≥ t)eβ
T
0 Z1(t)WA1 (t;θ0)]}






















Zi(t)WAi (t;θ0)− I(Ci ≥ t)eβ
T






0 Zi(t)WAi (t;θ0)]− n1/2E[I(C1 ≥ t)eβ
T
0 Z1(t)WA1 (t;θ0)] (B.47)










































































f̃π21,Ai (t) + op(1) (B.48)
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f̃π22,Ai (t) + op(1) (B.49)
Define f̃π23,Ai (t) = I(Ci ≥ t)eβ
T






Zi(t)ŴAi (t; θ̂)]−E[I(C1 ≥ t)eβ
T
0 Z1(t)WA1 (t;θ0)]} = Gnf̃π2,A + op(1)
(B.50)
where f̃π2,Ai (t) = f̃
π21,A
i (t) + f̃
π22,A
i (t) + f̃
π23,A
i (t).
B.4.10.3 n1/2{π̂A0 (t)− π0(t)}
By the Donsker’s theorem, we have
n1/2
 Pnf̃π1,A − P f̃π1,A





where Gf̃π1,A and Gf̃π2,A are tight Gaussian process on (0, τ ].
By Delta method we have
n1/2[π̂A0 − π0] =⇒ G





B.4.11 n1/2{π̂B0 (t)− π0(t)}
Following similar arguments we have
n1/2[π̂B0 − π0] =⇒ G





f̃π1,Bi (t) = f̃
π11,B
i (t) + f̃
π12,B
i (t)
f̃π11,Bi (t) = E
{






f̃π12,Bi (t) = I(Ci ≥ t)Ai(t)WBi (t;θ0)
f̃π2,Bi (t) = f̃
π21,B
i (t) + f̃
π22,B
i (t) + f̃
π23,B
i (t)















f̃π23,Bi (t) = I(Ci ≥ t)eβ
T
0 Zi(t)WBi (t;θ0)
B.5 Proof for Random Censoring
Suppose that we have a total of M imputations. Define ∆1i = I[C1i ≤ Di ∧ C2i], where Xi =
Di ∧C1i ∧C2i, Yi(t) = I(Xi ≥ t). Note that Yi(t) are the same for each imputed datasets, and for
the underlying knowing censoring dataset. Let γ̂ be the estimator of γ0 from the observed C1 data
{Xi,∆1i}ni=1. In finite samples, C
〈m〉
1i are imputed from the estimated conditional probabilities
with parameters γ̂, which converge almost surely to the true value. It can then be shown that
I(C
〈m〉
1i ≥ t; γ̂) and I(C
〈m〉











1i ≥ t;γ0) + op(1)
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Asymptotically, our imputed censoring time are drawn from the underlying true conditional
probability with γ0. More detailed proofs could be referred to a previous manuscript ”Semipara-
metric Temporal Process Regression of Survival-Out-of-Hospital”.
For the large sample properties of β̂A(M), we have




















H [β,θ,WA(θ)][ΩC2 ]−1uC2i (θ)+∫ τ
0










1i ≥ t;γ)I(C2i ≥ t)dt
Similarly, we could develop the asymptotic properties of β̂B(M).















1i ≥ t; γ̂)I(C2i ≥ t)WAi (t;θ0)exp[β̂
T
Zi(t)]
We could show that
n1/2[π̂A0 (M)− π0] =⇒ G


















1i ≥ t;γ0)I(C2i ≥ t)eβ
T
0 Zi(t)WAi (t;θ0)
The asymptotic properties of π̂B0 (t,M) could be obtained following parallel arguments.
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D. Bates, M. Mächler, B. Bolker, and S. Walker. Fitting linear mixed-effects models using lme4.
Journal of Statistical Software, 67(1):1–48, 2015. doi: 10.18637/jss.v067.i01.
N. E. Breslow. Contribution to the discussion of the paper by D.R. Cox. Journal of the Royal
Statistical Society, Series B, 34(2):216–217, 1972.
N. E. Breslow and D. G. Clayton. Approximate inference in generalized linear mixed models.
Journal of the American statistical Association, 88(421):9–25, 1993.
R. C. Carson, M. Juszczak, A. Davenport, and A. Burns. Is maximum conservative management
an equivalent treatment option to dialysis for elderly patients with significant comorbid disease?
Clinical Journal of the American Society of Nephrology, 4(10):1611–1619, 2009.
Y.-Y. Chi and J. G. Ibrahim. Joint models for multivariate longitudinal and multivariate survival
data. Biometrics, 62(2):432–445, 2006.
B. F. Cole, R. D. Gelber, and A. Goldhirsch. Cox regression models for quality adjusted survival
analysis. Statistics in medicine, 12(10):975–987, 1993.
R. J. Cook and J. F. Lawless. Marginal analysis of recurrent events and a terminating event.
Statistics in medicine, 16(8):911–924, 1997.
R. J. Cook, J. F. Lawless, L. Lakhal-Chaieb, and K.-A. Lee. Robust estimation of mean functions
and treatment effects for recurrent events under event-dependent censoring and termination:
95
application to skeletal complications in cancer metastatic to bone. Journal of the American
Statistical Association, 104(485):60–75, 2009.
D. R. Cox. Regression models and life tables (with discussion). Journal of the Royal Statistical
Society, 34:187–220, 1972a.
D. R. Cox. Regression models and life tables (with discussion). Journal of the Royal Statistical
Society, 34:187–220, 1972b.
D. R. Cox. Partial likelihood. Biometrika, pages 269–276, 1975.
A. P. Dempster, N. M. Laird, and D. B. Rubin. Maximum likelihood from incomplete data via the
em algorithm. Journal of the royal statistical society. Series B (methodological), pages 1–38,
1977.
B. Efron and R. J. Tibshirani. An introduction to the bootstrap. CRC press, 1994.
J. P. Estes, D. V. Nguyen, L. S. Dalrymple, Y. Mu, and D. Şentürk. Time-varying effect modeling
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